New blood vessels originating from the corneal veins and extending from the limbus into the adjacent CORNEAL STROMA. Neovascularization in the superficial and/or deep corneal stroma is a sequel to numerous inflammatory diseases of the ocular anterior segment, such as TRACHOMA, viral interstitial KERATITIS, microbial KERATOCONJUNCTIVITIS, and the immune response elicited by CORNEAL TRANSPLANTATION.
Injury to any part of the eye by extreme heat, chemical agents, or ultraviolet radiation.
A highly caustic substance that is used to neutralize acids and make sodium salts. (From Merck Index, 11th ed)
The transparent anterior portion of the fibrous coat of the eye consisting of five layers: stratified squamous CORNEAL EPITHELIUM; BOWMAN MEMBRANE; CORNEAL STROMA; DESCEMET MEMBRANE; and mesenchymal CORNEAL ENDOTHELIUM. It serves as the first refracting medium of the eye. It is structurally continuous with the SCLERA, avascular, receiving its nourishment by permeation through spaces between the lamellae, and is innervated by the ophthalmic division of the TRIGEMINAL NERVE via the ciliary nerves and those of the surrounding conjunctiva which together form plexuses. (Cline et al., Dictionary of Visual Science, 4th ed)
Formation of new blood vessels originating from the retinal veins and extending along the inner (vitreal) surface of the retina.
A pathological process consisting of the formation of new blood vessels in the CHOROID.
The administration of substances into the eye with a hypodermic syringe.
Usually a hydroxide of lithium, sodium, potassium, rubidium or cesium, but also the carbonates of these metals, ammonia, and the amines. (Grant & Hackh's Chemical Dictionary, 5th ed)
Agents and endogenous substances that antagonize or inhibit the development of new blood vessels.
A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions.
The original member of the family of endothelial cell growth factors referred to as VASCULAR ENDOTHELIAL GROWTH FACTORS. Vascular endothelial growth factor-A was originally isolated from tumor cells and referred to as "tumor angiogenesis factor" and "vascular permeability factor". Although expressed at high levels in certain tumor-derived cells it is produced by a wide variety of cell types. In addition to stimulating vascular growth and vascular permeability it may play a role in stimulating VASODILATION via NITRIC OXIDE-dependent pathways. Alternative splicing of the mRNA for vascular endothelial growth factor A results in several isoforms of the protein being produced.
Sterile solutions that are intended for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS.
The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example.
The development of new BLOOD VESSELS during the restoration of BLOOD CIRCULATION during the healing process.
Inflammation of the cornea.
The application of a caustic substance, a hot instrument, an electric current, or other agent to control bleeding while removing or destroying tissue.
Damage or trauma inflicted to the eye by external means. The concept includes both surface injuries and intraocular injuries.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
Stratified squamous epithelium that covers the outer surface of the CORNEA. It is smooth and contains many free nerve endings.
Cell adhesion molecules present on virtually all monocytes, platelets, and granulocytes. CD31 is highly expressed on endothelial cells and concentrated at the junctions between them.
Agents that induce or stimulate PHYSIOLOGIC ANGIOGENESIS or PATHOLOGIC ANGIOGENESIS.
A silver salt with powerful germicidal activity. It has been used topically to prevent OPHTHALMIA NEONATORUM.
The lamellated connective tissue constituting the thickest layer of the cornea between the Bowman and Descemet membranes.
Partial or total replacement of the CORNEA from one human or animal to another.
Disorder occurring in the central or peripheral area of the cornea. The usual degree of transparency becomes relatively opaque.
A family of angiogenic proteins that are closely-related to VASCULAR ENDOTHELIAL GROWTH FACTOR A. They play an important role in the growth and differentiation of vascular as well as lymphatic endothelial cells.
These growth factors are soluble mitogens secreted by a variety of organs. The factors are a mixture of two single chain polypeptides which have affinity to heparin. Their molecular weight are organ and species dependent. They have mitogenic and chemotactic effects and can stimulate endothelial cells to grow and synthesize DNA. The factors are related to both the basic and acidic FIBROBLAST GROWTH FACTORS but have different amino acid sequences.
Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity.
The mucous membrane that covers the posterior surface of the eyelids and the anterior pericorneal surface of the eyeball.
A superficial, epithelial Herpesvirus hominis infection of the cornea, characterized by the presence of small vesicles which may break down and coalesce to form dendritic ulcers (KERATITIS, DENDRITIC). (Dictionary of Visual Science, 3d ed)
The species Oryctolagus cuniculus, in the family Leporidae, order LAGOMORPHA. Rabbits are born in burrows, furless, and with eyes and ears closed. In contrast with HARES, rabbits have 22 chromosome pairs.
Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms.
Visualization of a vascular system after intravenous injection of a fluorescein solution. The images may be photographed or televised. It is used especially in studying the retinal and uveal vasculature.
The blood vessels which supply and drain the RETINA.
Highly specialized EPITHELIAL CELLS that line the HEART; BLOOD VESSELS; and lymph vessels, forming the ENDOTHELIUM. They are polygonal in shape and joined together by TIGHT JUNCTIONS. The tight junctions allow for variable permeability to specific macromolecules that are transported across the endothelial layer.
A form of fluorescent antibody technique commonly used to detect serum antibodies and immune complexes in tissues and microorganisms in specimens from patients with infectious diseases. The technique involves formation of an antigen-antibody complex which is labeled with fluorescein-conjugated anti-immunoglobulin antibody. (From Bennington, Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984)
A single-chain polypeptide growth factor that plays a significant role in the process of WOUND HEALING and is a potent inducer of PHYSIOLOGIC ANGIOGENESIS. Several different forms of the human protein exist ranging from 18-24 kDa in size due to the use of alternative start sites within the fgf-2 gene. It has a 55 percent amino acid residue identity to FIBROBLAST GROWTH FACTOR 1 and has potent heparin-binding activity. The growth factor is an extremely potent inducer of DNA synthesis in a variety of cell types from mesoderm and neuroectoderm lineages. It was originally named basic fibroblast growth factor based upon its chemical properties and to distinguish it from acidic fibroblast growth factor (FIBROBLAST GROWTH FACTOR 1).
Antibodies from non-human species whose protein sequences have been modified to make them nearly identical with human antibodies. If the constant region and part of the variable region are replaced, they are called humanized. If only the constant region is modified they are called chimeric. INN names for humanized antibodies end in -zumab.
Therapy using oral or topical photosensitizing agents with subsequent exposure to light.
Angiostatic proteins that are formed from proteolytic cleavage of COLLAGEN TYPE XVIII.
Partial or total replacement of all layers of a central portion of the cornea.
An extracellular matrix glycoprotein from platelets and a variety of normal and transformed cells of both mesenchymal and epithelial origin. Thrombospondin-1 is believed to play a role in cell migration and proliferation, during embryogenesis and wound repair. Also, it has been studied for its use as a potential regulator of tumor growth and metastasis.
Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components.
A 200-230-kDa tyrosine kinase receptor for vascular endothelial growth factors found primarily in endothelial and hematopoietic cells and their precursors. VEGFR-2 is important for vascular and hematopoietic development, and mediates almost all endothelial cell responses to VEGF.
A 180-kDa VEGF receptor found primarily in endothelial cells that is essential for vasculogenesis and vascular maintenance. It is also known as Flt-1 (fms-like tyrosine kinase receptor-1). A soluble, alternatively spliced isoform of the receptor may serve as a binding protein that regulates the availability of various ligands for VEGF receptor binding and signal transduction.
A variation of the PCR technique in which cDNA is made from RNA via reverse transcription. The resultant cDNA is then amplified using standard PCR protocols.
Diseases of the cornea.
The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell.
A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
The thin, highly vascular membrane covering most of the posterior of the eye between the RETINA and SCLERA.
A group of compounds containing the porphin structure, four pyrrole rings connected by methine bridges in a cyclic configuration to which a variety of side chains are attached. The nature of the side chain is indicated by a prefix, as uroporphyrin, hematoporphyrin, etc. The porphyrins, in combination with iron, form the heme component in biologically significant compounds such as hemoglobin and myoglobin.
A family of closely related RECEPTOR PROTEIN-TYROSINE KINASES that bind vascular endothelial growth factors. They share a cluster of seven extracellular Ig-like domains which are important for ligand binding. They are highly expressed in vascular endothelial cells and are critical for the physiological and pathological growth, development and maintenance of blood and lymphatic vessels.
Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes.
A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)
Restoration of integrity to traumatized tissue.
RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.
Tree-like, highly branched, polymeric compounds. They grow three-dimensionally by the addition of shells of branched molecules to a central core. The overall globular shape and presence of cavities gives potential as drug carriers and CONTRAST AGENTS.
The use of green light-producing LASERS to stop bleeding. The green light is selectively absorbed by HEMOGLOBIN, thus triggering BLOOD COAGULATION.
Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall.
Clarity or sharpness of OCULAR VISION or the ability of the eye to see fine details. Visual acuity depends on the functions of RETINA, neuronal transmission, and the interpretative ability of the brain. Normal visual acuity is expressed as 20/20 indicating that one can see at 20 feet what should normally be seen at that distance. Visual acuity can also be influenced by brightness, color, and contrast.
Nutrient blood vessels which supply the walls of large arteries or veins.
Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes.
The administration of substances into the VITREOUS BODY of the eye with a hypodermic syringe.
An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed.
Regulatory proteins and peptides that are signaling molecules involved in the process of PARACRINE COMMUNICATION. They are generally considered factors that are expressed by one cell and are responded to by receptors on another nearby cell. They are distinguished from HORMONES in that their actions are local rather than distal.
Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.
Either of two extremities of four-footed non-primate land animals. It usually consists of a FEMUR; TIBIA; and FIBULA; tarsals; METATARSALS; and TOES. (From Storer et al., General Zoology, 6th ed, p73)

In vivo significance of ICAM-1--dependent leukocyte adhesion in early corneal angiogenesis. (1/340)

PURPOSE: Numerous investigations have stressed the significance of leukocytes in early angiogenesis. Leukocytes invade the cornea, and the location of their extravasation corresponds to the site of vessel ingrowth. The interactions between leukocytes and vascular endothelium are mediated by various proteins, including adhesion molecules such as intercellular adhesion molecule-1 (ICAM-1). In this study, the role of ICAM-1 during early corneal angiogenesis was evaluated in vivo. METHODS: Corneal neovascularization was induced in New Zealand White rabbits by use of intrastromal pellets containing 750 ng vascular endothelial growth factor (VEGF). The fluorescent dye rhodamine 6G was used to stain leukocytes in vivo. Leukocyte adhesion and vessel growth were quantified in vivo by high-resolution fluorescence angiography. To inhibit ICAM-1 interactions a microemulsion containing anti-ICAM-1 antibody was applied topically. RESULTS: Limbal vessels showed increased leukocyte adhesion 24 hours after pellet implantation: The number of rolling and sticking leukocytes was significantly increased compared with the number in control animals (P < 0.01). Treatment with anti-ICAM-1 antibody resulted in reduced leukocyte sticking and increased leukocyte rolling. The area covered by new blood vessels was significantly diminished in eyes treated with anti-ICAM-1 (P < 0.05). CONCLUSIONS: The results support the hypothesis that ICAM-1-mediated leukocyte adhesion is a key event in early angiogenesis. This model may serve for investigation of the significance of adhesion molecules by in vivo observation and quantification.  (+info)

Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis. (2/340)

Proteolytic enzymes are involved in generation of a number of endogenous angiogenesis inhibitors. Previously, we reported that angiostatin, a potent angiogenesis inhibitor, is a proteolytic fragment containing the first four kringle modules of plasminogen. In this report, we demonstrate that urokinase-activated plasmin can process plasminogen to release an angiogenesis inhibitor, K1-5 (protease-activated kringles 1-5). K1-5 inhibits endothelial-cell proliferation with a half-maximal concentration of approximately 50 pM. This inhibitory effect is endothelial-cell-specific and appears to be at least approximately 50-fold greater than that of angiostatin. A synergistic efficacy of endothelial inhibition was observed when angiostatin and kringle 5 (K5) were coincubated with capillary endothelial cells. The synergistic effect is comparable to that produced by K1-5 alone. Systemic treatment of mice with K1-5 at a low dose significantly blocked the fibroblast growth factor-induced corneal neovascularization, whereas angiostatin had no effect at the same dose. K1-5 also suppressed angiogenesis in chicken embryos. Systemic administration of K1-5 at a low dose at which angiostatin was ineffective significantly suppressed the growth of a murine T241 fibrosarcoma in mice. The antitumor effect correlates with the reduced neovascularization. These findings suggest that the plasmin-mediated proteolysis may be involved in the negative switch of angiogenesis.  (+info)

Expression of cell adhesion molecules on limbal and neovascular endothelium in corneal inflammatory neovascularization. (3/340)

PURPOSE: To investigate the expression of cell-adhesion molecules on corneolimbal and neovascular endothelium and the associated leukocyte infiltration in an experimental model of inflammatory corneal neovascularization (NV). METHODS: Corneal NV was induced in BALB/c mice by placement of nylon sutures. Interleukin-1 receptor antagonist (IL-1ra) was used topically to determine whether suppression of IL-1 could affect adhesion molecule expression and leukocytic infiltration. At set time points, corneal samples were analyzed immunohistochemically for expression of P-selectin, E-selectin, intercellular adhesion molecule (ICAM)-1, vascular adhesion molecule (VCAM)-1, and platelet- endothelial adhesion molecule (PECAM)-1. Leukocytic infiltration at different time points was quantified histologically. In companion experiments mice deficient in ICAM-1 were investigated to determine the functional relevance of this molecule in corneal leukocyte infiltration. RESULTS: Significant enhanced expression of ICAM-1 was detected on the corneolimbal vascular endothelium as early as 8 hours and on the newly formed corneal NV by day 3, and treatment with IL-1ra led to significant suppression of this expression. IL-1ra-induced suppression of ICAM-1 expression was accompanied by a profound decrease in corneal leukocytic infiltration by 44.6% at day 1 (P < 0.003), 71.8% at day 3 (P < 0.001), 60.1% at day 7 (P < 0.001), and 63.8% at day 14 (P < 0.001), compared with control corneas. Similarly, in ICAM-1 knockout mice, the corneal leukocytic infiltration was 50.3%, 52.9%, and 36.4%, compared with wild-type control animals on day 1 (P < 0.001), day 7 (P < 0.005), and day 14 (P < 0.001), respectively. Expression of PECAM-1 was constitutively present on perilimbal vascular endothelium and had no response to IL-1ra treatment. No significant expression of P-selectin, E-selectin, or VCAM-1 was detected in this experimental model. CONCLUSIONS: These results suggest that leukocytic infiltration in this model of inflammatory corneal NV is closely associated with ICAM-1 expression, and that topical IL-1ra displays corneal anti-inflammatory effects, largely by suppressing ICAM-1 expression on vascular endothelial cells.  (+info)

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. (4/340)

Vascular endothelial growth factor (VEGF) has been shown to promote neovascularization in animal models and, more recently, in human subjects. This feature has been assumed to result exclusively from its direct effects on fully differentiated endothelial cells, i.e. angiogenesis. Given its regulatory role in both angiogenesis and vasculogenesis during fetal development, we investigated the hypothesis that VEGF may modulate endothelial progenitor cell (EPC) kinetics for postnatal neovascularization. Indeed, we observed an increase in circulating EPCs following VEGF administration in vivo. VEGF-induced mobilization of bone marrow-derived EPCs resulted in increased differentiated EPCs in vitro and augmented corneal neovascularization in vivo. These findings thus establish a novel role for VEGF in postnatal neovascularization which complements its known impact on angiogenesis.  (+info)

Inhibition of rat corneal angiogenesis by 16-kDa prolactin and by endogenous prolactin-like molecules. (5/340)

PURPOSE: The cornea is an avascular organ, where induction of new blood vessels involves the turn-on of proangiogenic factors and/or the turn-off of antiangiogenic regulators. Prolactin (PRL) fragments of 14 kDa and 16 kDa bind to endothelial cell receptors and inhibit angiogenesis. This study was designed to determine whether antiangiogenic PRL-like molecules are involved in cornea avascularity. METHODS: Sixteen-kDa PRL and basic fibroblast growth factor (bFGF) or anti-PRL antibodies were placed into rat cornea micropockets and neovascularization evaluated by the optical density associated with capillaries stained by the peroxidase reaction and by the number of vessels growing into the implants. Prolactin receptors in corneal epithelium were investigated by immunocytochemistry. RESULTS: bFGF induced a dose-dependent stimulation of corneal neovascularization. This effect was inhibited by coadministration of 16-kDa PRL, as indicated by a 65% reduction in vessel density and a 50% decrement in the incidence of angiogenic responses. Corneal angiogenic reactions of different intensities were induced by implantation of polyclonal and monoclonal anti-PRL antibodies. Corneal epithelial cells were labeled by several anti-PRL receptor monoclonal antibodies. CONCLUSIONS: These findings show that exogenous 16-kDa PRL inhibits bFGF-induced corneal neovascularization and suggest that PRL-like molecules with antiangiogenic actions function in the cornea. PRL receptors in the corneal epithelium may imply that PRL in the cornea derives from lacrimal PRL internalized through an intracellular pathway. These observations are consistent with the notion that members of the PRL family are potential regulators of corneal angiogenesis.  (+info)

Nitric oxide synthase-II is expressed in severe corneal alkali burns and inhibits neovascularization. (6/340)

PURPOSE: Inducible nitric oxide synthase (NOS-II) is expressed in many inflammatory conditions. The implication of nitric oxide (NO) in angiogenesis remains controversial. The role of NOS-II and its influence on angiogenesis in corneal neovascularization is unknown and was investigated in this study. METHODS: A mouse model of corneal neovascularization induced by chemical cauterization was used. NOS-II mRNA expression was analyzed by reverse transcriptase-polymerase chain reaction, and NOS-II protein was studied in situ by immunohistochemical analysis of the cornea. The influence of NOS-II on neovascularization was determined by comparison of vessel development in "normal" wild-type mice and mice with a targeted disruption of the NOS-II gene. RESULTS: NOS-II mRNA was induced to very high levels after corneal cauterization and remained upregulated throughout the disease. Migratory cells in the center of the cauterization area expressed NOS-II protein. The neovascular response in mice lacking the NOS-II gene was significantly stronger than in wild-type mice, and the difference increased over time. CONCLUSIONS: These data are the first evidence that NOS-II is expressed in this model of sterile corneal inflammation. NOS-II expression inhibited angiogenesis in severe corneal alkali burns.  (+info)

IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis. (7/340)

Few studies have addressed the importance of vascular remodeling in the lung during the development of bleomycin-induced pulmonary fibrosis (BPF). For fibroplasia and deposition of extracellular matrix to occur, there must be a geometric increase in neovascularization. We hypothesized that net angiogenesis during the pathogenesis of fibroplasia and deposition of extracellular matrix during BPF are dependent in part on a relative deficiency of the angiostatic CXC chemokine, IFN-gamma-inducible protein-10 (IP-10). To test this hypothesis, we measured IP-10 by specific ELISA in whole lung homogenates in either bleomycin-treated or control mice and correlated these levels with lung hydroxyproline. We found that lung tissue from mice treated with bleomycin, compared with that from saline-treated controls, demonstrated a decrease in the presence of IP-10 that was correlated to a greater angiogenic response and total lung hydroxyproline content. Systemic administration of IP-10 significantly reduced BPF without any alteration in lung lymphocyte or NK cell populations. This was also paralleled by a reduction in angiogenesis. Furthermore, IP-10 had no direct effect on isolated pulmonary fibroblasts. These results demonstrate that the angiostatic CXC chemokine, IP-10, inhibits fibroplasia and deposition of extracellular matrix by regulating angiogenesis.  (+info)

Effects of 1alpha,25-dihydroxyvitamin D3 on Langerhans cell migration and corneal neovascularization in mice. (8/340)

PURPOSE: To examine the effects of 1alpha,25-dihydroxyvitamin D3 (1alpha,25[OH]2D3), a hormone that has immunosuppressive properties, on Langerhans cell (LC) migration and corneal neovascularization in mouse corneas. METHODS: Two 10-0 nylon interrupted sutures were placed in the center of 50 BALB/c mouse corneas to induce LC migration and corneal neovascularization. The mice were then randomly assigned to one of five groups. Three groups (n = 11, n = 11, n = 6) received topical 1alpha,25(OH)2D3 (at concentrations of 10(-7) M, 10(-)8 M, 10(-9) M), one group (n = 11) received vehicle only, and one group (n = 11) received no eye drops. Instillation (three times a day) began on the first day after suturing. Corneal neovascularization was assessed by slit lamp microscopy and scored according to the length of newly formed corneal vessels. Fourteen days after suturing, the number of LCs that had migrated into the central corneal epithelium was counted by an immunofluorescence assay using an anti-Ia antibody. RESULTS: The number of LCs in the central cornea was 21.9 +/- 2.8 cells/mm2 in the nontreated group and 17.8 +/- 3.9 cells/mm2 in the vehicle-only group. Significantly fewer LCs were detected in all groups that had received 1alpha,25(OH)2D3 compared with the vehicle only and nontreated groups (10(-7) M: 7.4 +/- 1.2 cells/mm2, 10(-8) M: 7.2 +/- 2.0 cells/mm2, 10(-9) M: 6.2 +/- 0.7 cells/mm2). Moderate inhibition of corneal vascularization was observed in the 10(-7) M 1alpha,25(OH)2D3 group, but not the other groups. CONCLUSIONS: Topical administration of 1alpha,25(OH)2D3 can be effective in suppressing ocular surface inflammation by inhibiting LC migration into mouse corneas.  (+info)

Purpose: : To evaluate the effect of topically administered diclofenac, ketorolac, and etanercept on experimental corneal neovascularization. Methods: : Chemical cauterization of the cornea in 32 eyes of 32 rats was performed using silver nitrate sticks to induce corneal neovascularization. Topical instillation of diclofenac (Volteran, Novartis Pharmaceuticals), ketorolac (Acular, Allergan), and etanercept (Enbrel, Immunex Corp.) was compared to normal saline treatment for inhibition of neovascularization for 7 days. All animals were treated in accordance with the ARVO guidelines on the care and use of animals in research. The animals were randomly divided in 4 groups. Group 1 (n=8) received balanced salt solution (control), group 2 (n=8) received ketorolac 0.5 %, group 3 (n=8) received diclofenac 0.1%, and group 4 (n=8) received 200 µg/ml of etanercept. Percentage area of cornea covered by neovascularization and scar in each group was calculated separately by use of computer software on ...
The purpose of the study is to test the investigational drug Gamunex-C on the growth of blood vessels over the cornea. This study is being conducted by Dr. Balamurali Ambati at the Moran Eye Center at the University of Utah.. The cornea is the clear outer front part of the eye. In corneal neovascularization, blood vessels grow over the cornea. Corneal neovascularization and ocular anterior segment inflammations are sight-threatening conditions. Lipid deposition and edema with subsequent scar formation can compromise corneal clarity irreversibly. Corneal neovascularization is also a well recognized risk factor for corneal graft failure. In its natural state, the cornea is a site of immune privilege well suited to tissue transplantation. Once vascularized, there is direct exposure of corneal antigens to circulating host immune mechanisms greatly increasing the chance of rejection [Collaborative Corneal Transplantation Study].. Melting or inflammation in the anterior chamber, cornea, or ocular ...
Corneal neovascularization (CNV) is the in-growth of new blood vessels from the pericorneal plexus into avascular corneal tissue as a result of oxygen deprivation. Maintaining avascularity of the corneal stroma is an important aspect of corneal pathophysiology as it is required for corneal transparency and optimal vision. A decrease in corneal transparency causes visual acuity deterioration. Corneal tissue is avascular in nature and the presence of vascularization, which can be deep or superficial, is always pathologically related. Corneal neovascularization is a sight-threatening condition that can be caused by inflammation related to infection, chemical injury, autoimmune conditions, post-corneal transplantation, and traumatic conditions among other ocular pathologies. Common causes of CNV within the cornea include trachoma, corneal ulcers, phylctenular keratoconjunctivitis, rosacea keratitis, interstitial keratitis, sclerosing keratitis, chemical burns, and wearing contact lenses for ...
Pathologic angiogenesis is involved in cancer and several blinding conditions such as wet age-related macular degeneration, proliferative retinopathies and corneal neovascularization.. In these dieseases, the angiogenic triggers are hypoxia and inflammation, and both involve the main angiogenic mediator, which is Vascular Endothelial Growth Factor (VEGF). Among available treatments, anti-VEGF often shows limited or temporary efficacy, while steroids are potentially responsible for many side-effects. This thesis presents a series of linked studies aimed at elucidating the early pathologic changes leading to inflammation and corneal neovascularization, and how various treatments affect this process. In this thesis, anti-inflammatory and anti-angiogenic treatments are applied in corneal neovascularization models, to identify VEGF-independent pathways and other novel factors as future therapy targets, as well as to investigate the endogenous modulation of angiogenesis.. A model of experimental ...
Corneal Neovascularization (CNV), the extensive growth of blood vessels from conjunctiva into the cornea. It is a sight-threatening condition that can decreases eyesight and even leads to blindness. The pathologic growth of blood vessels impairs light transmission, promotes scar formation and causes inflammations, which harm visual acuity. Abnormal angiogenesis plays an important role in the process of CNV, which may result from corneal wound healing. Neovascular eye disease is one of the most common eye diseases in clinical admissions. CNV blinds approximately 7 million people worldwide. Continued mechanistic studies are a key to the prevention and treatment of CNV. Research in CNV animal models is essential in eye diseases. Several main methods of CNV models preparation are summarized in this review.. ...
Due to its noninvasive accessibility and clarity, cornea serves an ideal target for evaluating the efficacy of various treatments against corneal disorders. A multitude of potential gene therapies based on different genes and strategies have been tried in the context of corneal diseases, including corneal NV. For example, various viral-mediated gene delivery systems have been proposed to produce expression of the desired genes with varying expression levels and duration [32-34]. In the case of gene therapy for corneal NV, as in many other situations, it is well recognized that targeting a single gene often fails to ensure the theoretically predicted efficacy [23,35-37]. We therefore investigated the possibility of better management of corneal NV by combining different anti-angiogenic factors in the present study. We showed that the combination of two or three genes exhibited additive effects over a single gene in inhibiting HUVEC proliferation in vitro (Figure 1A). This additive effect, however, ...
TY - CHAP. T1 - Corneal suturing techniques. AU - Lee, W. Barry. AU - Mannis, Mark J. PY - 2007. Y1 - 2007. N2 - Suturing technique remains one of the most vital skills in the art of contemporary corneal surgery. Although the main purpose of suture placement remains adequate wound apposition and closure, meticulous attention to appropriate suture placement cannot only minimize postoperative astigmatism, but also may facilitate more rapid visual recovery and lead to a more stable wound long term. A variety of factors remain critical for suture placement, including avoidance of mismatch between radial and nonradial suture bite placement, appropriate donor and recipient bite lengths, appropriate bite depth, and symmetrical and adequately dispersed suture tension in each quadrant of the cornea, with special care to prevent excessive tightening. Th e evolution of corneal suturing techniques from overlay sutures to direct appositional suture closure, along with the discovery of small, monofilament ...
Anti-VEGF antibodies including off-label bevacizumab (Avastin™, Genentech), ranibizumab (Lucentis™, Genentech), and aflibercept (VEGF Trap-eye (VTE), Eylea) are presently used for the management of various retinal vascular abnormalities [72]. These drugs are different in their pharmacokinetics, structure, and molecular weight. Ranibizumab and aflibercept, which received Food and Drug Administration (FDA) approval for the treatment of neovascular age-related macular degeneration, were designed specifically for intravitreal injection.. Bevacizumab is a full-length humanized murine monoclonal IgG1 antibody with a molecular weight of 149 kDa that received FDA approval for the management of different cancers. 93% and 7% of amino acid sequences of this drug are similar to the human IgG1 and murine antibody, respectively [73]. Bevacizumab recognizes all isoforms of VEGF-A. Despite being off-label, it is used commonly as an intravitreal injection for the management of various retinal diseases [74]. ...
MicroRNA-184 down-regulated the levels of VEGF and β-catenin of HCE cells. Western blotting was performed to detect protein levels of VEGF and β-catenin in the transfected HCE cells. (A) Representative images of Western blotting of VEGF in the HCE cells transfected with scramble or the mimic of miR-184 for 48 hours. (B) Statistical analysis of Western blotting data of VEGF of the HCE cells transfected with scramble or the mimic of miR-184 for 48 hours. (Data are presented as mean ± SEM, n = 3 in each group, **P , 0.01.) (C) Representative images of Western blotting of VEGF in the HCE cells transfected with scramble or the inhibitor of miR-184 for 48 hours. (D) Statistical analysis of Western blotting data of VEGF of the HCE cells transfected with scramble or the inhibitor of miR-184 for 48 hours. (Data are presented as mean ± SEM, n = 3 in each group, ***P , 0.001.) (E) Representative images of Western blotting of β-catenin in the HCE cells transfected with scramble or the mimic of miR-184 ...
10 patients will complete a course of treatment with placebo, followed by a course of treatment with 5% custom made topical IL-1Ra.. IL-1Ra : 5% custom made topical IL-1Ra 3 times a day in both eyes for a period of 6 weeks. Placebo : Custom eye drop eye three times a day in both eyes for a period of 6 weeks. ...
Gene Signal is currently developing aganirsen GS-101 (an antisense oligonucleotide or short naturally occurring DNA strand). GS-101 is a topical medication in the form of eye drops, and is currently being researched for the management of excessive vascular growth in the cornea, also known as neovascularisation GS-101 is a copy of a naturally occurring human gene and acts by inhibiting the expression of IRS-1, a protein required for the formation and growth of new blood vessels. By blocking the expression of this protein in pro-angiogenic conditions (in this case, those with excessive vascular growth), GS-101 inhibits and regresses corneal neovascularisation, which interferes with vision and may be the cause of graft rejection. Phase I, Phase II and Phase III clinical studies have been completed for Gene Signal s GS-101 in the management of Corneal Graft Rejection associated with Neovascularisation (excessive vascular growth of the cornea). The Phase I trial evaluated the safety of GS-101 is ...
Inflammatory angiogenesis is the pathogenic mechanism of various sight-threatening eye diseases, among them corneal neovascularization. Current treatment options include steroids which have undesirable side effects, or anti-VEGF which has only limited efficacy. In an inflammatory environment, however, angiogenesis can be stimulated by numerous factors not directly targeted by anti-VEGF therapy. The aim of this study was to induce corneal inflammation leading to angiogenesis, and investigate the early, differential effects of steroid and anti-VEGF therapy at the cellular, tissue, and gene expression levels. Fifty-two Wistar rats received a single intrastromal corneal suture to induce a controlled inflammatory angiogenic response. Rats were subsequently treated with dexamethasone, rat specific anti-VEGF, or goat IgG (control), topically 4 times daily for 7 days. In vivo confocal microscopy of the cornea was performed longitudinally from 5 h up to 7 d to investigate morphology at the cellular and ...
OXB-202Gene-based treatment for corneal graft rejectionStatus: Phase I/II study in preparationCorneal graft rejectionCornea grafts are one of the most successful tissue transplants, but over time a significant number are rejected due to corneal neovascularisation. Currently, approximately 100,000 transplants are performed each year, but with this representing only 1% of those requiring treatment the number is predicted to increase substantially. Our approach
Results Autologous cultivated oral mucosal epithelial sheets were successfully generated for all 17 patients. All patients were followed up for more than 36 months; the mean follow-up period was 55 months and the longest follow-up period was 90 months. During the long-term follow-up period, postoperative conjunctivalisation and symblepharon were significantly inhibited. All eyes manifested various degrees of postoperative corneal neovascularisation, but it gradually abated and its activity was stable at 6 months after surgery. Best-corrected visual acuity was improved in 18 eyes (95%) during the follow-up periods, and visual acuity at the postoperative 36th month was improved in 10 eyes (53%). ...
RESULTS: The receptors for LXA4, ALX/Fpr-rs-2 and for RvE1, ChemR23 were each expressed by epithelium, stromal keratocytes, and infiltrated CD11b(+) cells in corneas. Compared to the vehicle-treated eye, ATLa-, RvD1-, and RvE1-treated eyes had reduced numbers of infiltrating neutrophils and macrophages and reduced mRNA expression levels of TNF-alpha, IL-1 alpha, IL-1 beta, VEGF-A, VEGF-C, and VEGFR2. Animals treated with these mediators had significantly suppressed suture-induced or IL-1 beta-induced hemangiogenesis (HA) but not lymphangiogenesis. Interestingly, only the application of ATLa significantly suppressed VEGF-A-induced HA ...
Imagine its late, youre really tired and you just want to sleep. You might be tempted to skip removing your contacts and head straight to bed.. But before you climb under the covers, its really important that you take your contacts out. Sleeping in contacts can compromise the health of your eyes. More specifically, heres what can happen:. Your eyes can be deprived of oxygen. Your cornea, the part of your eye you place a contact on top of, needs oxygen from the air. Wearing contacts blocks oxygen from getting to your cornea. This only gets worse when your eyes are closed during sleep.. New blood vessels may start to form on corneas that arent getting enough oxygen. This condition, called corneal neovascularization, can cause a permanent reduction in vision, blurry vison or eye infections. The resulting damage can prevent you from wearing contact lenses or being a candidate for LASIK surgery in the future.. You could get a bacterial infection. Sleeping in contacts increases your risk of ...
2016. Ardan, T., Němcová, L., Bohuslavová, B., Klezlová, A., Popelka, Š., Studenovská, H.3, Hrnčiarová, E., Čejková, J., Motlík, J.: (2016) Reduced Levels of Tissue Inhibitors of Metalloproteinases (TIMPs) in UVB Irradiated Corneal Epithelium. Photochem. Photobiol., IN PRESS IF 2.008. Bílková, B., Albrecht, T., Chudičková, M., Holáň, V., Piálek, J., Vinkler, M.: (2016) Application of Concanavalin A during immune responsiveness skin-swelling tests facilitates measurement interpretation in mammalian ecology. Ecology and Evolution, 6 (13): 4551-4564. IF 2.537. Čejka, Č., Čejková, J., Trošan, P., Zajícová, A., Syková, E., Holáň, V.: (2016) Transfer of mesenchymal stem cells and cyclosporine A on alkali-injured rabbit cornea using nanofiber scaffolds strongly reduces corneal neovascularization and scar formation. Histol. Histopath., 31: 969-980. IF 1.875. Čejka, Č., Holáň, V., Trošan, P., Zajicová, A., Javorková E., Čejková, J.: (2016) The Favorable Effect of ...
Corneal neovascularization (NV) is a major cause of blindness worldwide. Our research objective is to identify the role of membrane type 1 matrix metalloprotein...
Patient had surgery and returns complaining of FB sensation due to suture placement. Physician gave pt. bangage contact lens to alleviate FB sensation
Corneal Angiogenesis The cornea, viiagra transparent window of the eye, normally is completely devoid of blood and lymph vessels, which is an indispensable prerequisite for good vision. He had a fever (39.
Opacities,comealnerves and limbal vessels When using the slit lamp, direct and indirect illumination are viewed simultaneously,structures viewed in the alesse 28 start taking Field are seen under acne after stopping alesse illumination, but as this does not fill the whole of the field of view, anything which reflects or scatters light from outside the illuminated alesse 28 start taking is being viewed by indirect illumination To view takingg features by indirect illumination, first locate il by direct illumination and keeping the viewing system unchanged, swing the lamp to one side. Start here for terms t aking use.
PURPOSE To report the outcomes of corneal fine needle diathermy (FND) with adjuvant intrastromal and subconjunctival bevacizumab injection for corneal neovascularization (CN) in children. METHODS Medical records of all children who had undergone FND with adjuvant bevacizumab injection were reviewed retrospectively. Treatment efficacy was evaluated by changes in visual acuity, regression of CN, and clearing of lipid deposits with the aid of slit-lamp color images that were taken before surgical intervention and at last follow-up visit. Postoperative complications were recorded and served to assess the safety of the procedure. RESULTS Nine eyes of 9 patients were included in the study. The mean age of the patients was 8.4 ± 4.2 years (4-15 years) and the mean follow-up time was 18.7 ± 12.2 months (5-35 months). Three eyes had a history of herpes simplex keratitis (HSK), 3 eyes had complete corneal anesthesia, 2 eyes had CN following suture tract infection after corneal transplant for HSK scar and
TY - JOUR. T1 - Method for Angiographically Guided Fine-Needle Diathermy in the Treatment of Corneal Neovascularization. AU - Romano, Vito. AU - Steger, Bernhard. AU - Brunner, Matthias. AU - Ahmad, Sajjad. AU - Willoughby, Colin. AU - Kaye, Stephen B.. PY - 2016/3/9. Y1 - 2016/3/9. N2 - PURPOSE:To describe a method to assess corneal neovascular (CoNV) complexes and identify feeder vessels for selective arterial fine-needle diathermy (FND).METHODS:In patients with CoNV, color photography and corneal indocyanine green angiography (ICGA) and fluorescein angiography are performed. After injection of indocyanine green and sodium fluorescein dye, videography and single-frame images of the region of interest are recorded. Videography is used to measure the time to leakage to assess vessel maturity to guide medical treatment and to discern afferent from efferent vessels. Single-frame images are then selected to locate the number of afferent vessels for surgery, which are selectively cut with a 25-gauge ...
Corneal angiogenesis assay of wt and c-abl-deficient mice. VEGF-saturated or PBS sham Hydron pellets were implanted in corneas of 3-wk-old mice and 7 d postim
10 patients with severe corneal neovascularisation (5 after corneal transplant and 5 after infectious keratitis). Injection of Avastin at a dose of 1,25 mg was given subconjunctivally. Patiens were followed-up for 4 weeks, if inhibition result was unsatisfactory injection was repeated ...
Aganirsen eye drops demonstrated significant benefits among patients with keratitis, as well as in patients with viral keratitis and central neovascularization, according to the results of a recent study. The multicenter, double-masked, phase 3 study included 69 patients with keratitis-related progressive corneal neovascularization who were randomized to use either aganirsen drops (86
This is our initial experience with FND represented in only 2 cases, therefore definitive conclusions couldnt be established. Nevertheless, based on our results and after reviewing the two largest series published since FND was described, we found this technique simple, inexpensive and effective in occluding established corneal vessels, the main recognized risk factor for corneal graft rejection and failure. The lack of any major intra and postoperative complications reinforces the safety profile of the procedure. FND can be repeated and performed in any small eye unit around the world, as it does not require specialized equipment ...
Therapy for Ocular Angiogenesis: Principles and Practice covers the basic pathophysiology of ocular angiogenesis and strategies for inhibition.
Salmon Saturday: Because there are so many great ways to prepare salmon and someone has to start writing them down. Take these ideas and make them your own. Its about 6:30am on Saturday morning and I have no Salmon Saturdays ready to launch. I have ideas of what I could write, but nothing really inspired…
The I-CAN study was the first randomised trial of a topical inhibitor of corneal angiogenesis. It showed that topical applications of aganirsen are safe and well-tolerated, that it significantly reduces the relative area of corneal neovascularisation, and that the need for corneal transplantation is reduced in patients suffering from viral keratitis and central neovascularization About neovascularisation and Corneal Grafts The following Orphan Drug designations were granted to Gene Signal for GS 101 - antisense oligonucleotide: On November 7, 2016, the US Food and Drug Administration granted aganirsen an Orphan Drug Designation for Prevention of Corneal Graft Rejection. On 11 June 2014, Orphan designation (EU/3/14/1275) was granted by the European Commission to Gene Signal for aganirsen (GS-101) for the treatment of Central Retinal Vein Occlusion, the most common cause of Neovascular Glaucoma. On April 17, 2007, Orphan designation (EU/3/07/445) was granted by the European Commission to Gene ...
DESCRIPTION (provided by applicant): The overall aim of this grant is to elucidate the novel linkage between copper transport protein Antioxidant1 (Atox1) and NADPH oxidase involved in inflammatory angiogenesis. Ischemic disease is a leading cause of morbidity and mortality in worldwide. Neovascularization is an important repair process in response to ischemia, which depends on angiogenesis, inflammation and reactive oxygen species (ROS). Copper (Cu), an essential micronutrient, is involved in physiological repair processes such as wound healing and angiogenesis as well as in various pathophysiologies including tumor growth, atherosclerosis and inflammatory diseases. Since excess Cu is toxic, bioavailability of intracellular Cu is tightly controlled by Cu transport proteins such as Cu chaperone Atox1. Our laboratories provided the first evidence that Atox1 functions as a Cu-dependent transcription factor to regulate Cu-induced cell growth. Furthermore, we are one of the first to demonstrate that ...
Poster (2011, October). Cornea engraftment is the most common organ transplantation practiced around the world. The cornea is totally devoid of blood or lymphatic vessels, except in a peripheral zone called the limbus. This ... [more ▼]. Cornea engraftment is the most common organ transplantation practiced around the world. The cornea is totally devoid of blood or lymphatic vessels, except in a peripheral zone called the limbus. This property, named corneal angiogenic privilege, is conserved among all mammals to maintain cornea transparency and optimal visual acuity. In pathological conditions such as trauma, infections or hypoxia, blood and lymphatic vessels can grow into the avascular cornea, reducing visual acuity. In case of keratoplasty, it also considerably increases the risk of cornea graft rejection and is so considered as a high-risk keratoplasty. Treatments improving cornea survival after transplantation need to be developed, notably aiming at blocking corneal neovascularization. ...
We investigated the role of interleukin 8 (IL-8) in mediating angiogenesis in human bronchogenic carcinoma. Increased quantities of IL-8 were detected in tumor tissue as compared with normal lung tissue. Immunohistochemical staining of tumors revealed primary localization of IL-8 to individual tumor cells and demonstrated the capacity of tumor to elaborate IL-8. Functional studies that used tissue homogenates of tumors demonstrated the induction of both in vitro endothelial cell chemotaxis and in vivo corneal neovascularization. It is important to note that the addition of neutralizing antisera to IL-8 to these assays resulted in the marked and specific attenuation of these responses. Our observations definitively establish IL-8 as a primary mediator of angiogenesis in bronchogenic carcinoma and offer a potential target for immunotherapies against solid malignancies. ...
Uses: High visibility fluorescent yellow skin sutures, making for easier suture placement, location and removal.. (Similar to Nylon Multi). ...
Your account has been temporarily locked Your account has been temporarily locked due to incorrect sign in attempts and will be automatically unlocked in 30 mins. For immediate assistance, contact Customer Service: 800-638-3030 (within the USA), 301-223-2300 (outside of the USA) [email protected] ...
A question that has been raised in deliberations over why angiogenesis trials in humans have not demonstrated the robust therapeutic effects seen in earlier animal studies is whether the end points chosen for these trials were correct; ie, what is the definition of successful therapeutic neovascularization? Furthermore, were the measurement tools that were used to capture such end points adequately sensitive to detect them, even if they were present? Most scientists and clinicians would agree that successful neovascularization requires that new blood vessels be functional, supply the ischemic region with blood, and be stable over time. Our patients would emphasize that irrespective of whether the treatment makes them live longer, they would like to feel better, and hence quality of life is an important end point. Here, we consider whether the identification of molecular markers of neovascularization adds useful information and/or should be incorporated into the definition of successful ...
TRY TO evaluate whether trapping vascular endothelial development element A (VEGF-A) would suppress angiogenesis and inflammation in dried out eye corneas inside a murine corneal suture magic size. buffered saline PBS). Corneas were harvested and immunohistochemical staining was performed to review the extents of Compact disc11b+ and neovascularization cell infiltration. Real-time polymerase string response was … Continue reading TRY TO evaluate whether trapping vascular endothelial development element A (VEGF-A). ...
Publications, Research Grants, Scientific Experts, Research Topics, Species, Genomes and Genes about physiologic neovascularization
Phenotypical signature of pro-angiogenic TEM.(A) In vivo corneal vascularization assay to assess the pro-angiogenic activity of TEM isolated from peripheral blo
I will start my gcmaf treatment in a month once i finish some tests and the doctor get the gcmaf bottles from europe ,, he said that he would start me...
Its been researched in relation to cancer, autism, and Alzheimers, but just what is GcMAF and how does it work? Dr. Connealy explains.
A limitation to the use of biologic therapies is the risk of significant systemic adverse events. Local administration achieves lower systemic exposure to the drug and therefore is likely associated with lower rates of severe adverse events. The use of infliximab eye drops has been investigated as an alternative modality for local drug delivery. The administration of topical infliximab eye drops reduced corneal opacity, perforation, and eyelid fibrosis in a mouse model of corneal alkali burn,19 and improved tear volume, corneal surface regularity, and goblet cell density in a mouse model of dry eye.20 In rabbit models, the use of topical infliximab prevented corneal neovascularization21 and suppressed subconjunctival wound healing after trabeculectomy.22 On the other hand, cerebrovascular accidents are recognized complications of systemic anti-VEGF therapy23 while anti-TNF-α agents are associated with a risk of opportunistic infections, malignancies, infusion reactions, as well as cardiac and ...
Rarely, patients with right-to-left shunting and subsequent transfusion requirementsas well as for sub viagra fetal tissue or by temporary derangements and treatment of children with hib meningitis. , answers i. Severe corneal neovascularization, which is the most common intraocular tumor in the low-risk summer season when aom is to help identify this event as a dynamic process presenting as vascular ring or orifice. Neonatal infections bacterial & spirochetal proteinuria, cylindruria, and minimal pi is normal. The spinous processes associated with clinical symptoms and signs achalasia is uncommon but include benign juvenile myoclonic epilepsy of childhood usually lead to fur-ther progression of long-term chronic transfusion therapy, however, and patients are not useful in pressure-controlled modes of mechanical ventilation a propen-sity analysis. Earlier postnatal ultrasound might underestimate the degree of organ involvement, neutropenia or thrombocytopenia associated with fat malabsorption ...
TY - JOUR. T1 - Angiogenic factor. T2 - A possible mechanism for neovascularization produced by omental pedicles. AU - Cartier, R.. AU - Brunette, I.. AU - Hashimoto, K.. AU - Bourne, W. M.. AU - Schaff, Hartzell V. PY - 1990. Y1 - 1990. N2 - To determine possible mechanisms by which omental pedicles protect bronchial anastomoses from ischemia, we studied the angiogenic potential of a lipid extract of omentum. A rabbit cornea model was used to quantify neovascularization produced by methanol-chloroform extract of homogenized autologous omentum or perirenal fat. In 22 anesthetized rabbits, 10 μl of omental lipid extract was injected into the cornea. In each animal the opposite eye was used as a control and was injected with a similar volume of extract prepared from perirenal fat. The side of injection of autologous omental fat was randomized and was not known to the investigator who assessed neovascularization on days 4, 7, 14, and 21 after injection. Neovascularization was recorded on ...
From time to time ophthalmic surgeons have tried to find some satisfactory means of closing the corneal wound after cataract extraction by mechanical means. Bri
Normal wound healing includes a number of overlapping phases. After injury, there is an early inflammatory step characterised by haemorrhage and clotting. At this time, the wound has a provisional serum-derived extracellular matrix, which serves to seal the wound temporarily and allows the invasion of cells that carry out the repair process. In the next phase, consisting of granulation tissue development, fibroblasts invade the wound and commence replacing the provisional matrix with a more mature wound matrix. The fibroblasts present during the early granulation tissue phase resemble immature fibroblasts with a highly synthetic appearance. However, as the granulation tissue phase proceeds, fibroblasts start showing a new phenotype with prominent contractile structures represented by microfilament bundles or stress fibres; these structures express contractile proteins typical of smooth muscle cells, particularly of vascular smooth muscle cells, such as α-smooth muscle actin [1]. Recently, it has been
Raquel Lima e Silva, Jikui Shen, Sean F Hackett, Shu Kachi, Hideo Akiyama, Katsuji Kiuchi, Katsutoshi Yokoi, Maria C Hatara, Thomas Lauer, Sadia Aslam, Yuan Yuan Gong, Wei-Hong Xiao, Naw Htee Khu, Catherine Thut, Peter A Campochiaro
These findings recommend that an inappropriate fibrotic reaction to persistent inflammation and neovascularization, particularly on the aortic facet, may lead
In vitro experiments conducted by Saisei Mirai indicate increased rate of maturation of dendritic cells (DCs), a type of immune cell, with 2nd Generation GcMAF. This graph shows specific marker expression of dendritic cells grown from normal peripheral blood with and without 2nd Generation GcMAF after 6 and 8 days cultivation. From this preliminary experiment we observed that 2nd Generation GcMAF increases the rate of maturation of dendritic cells. The ability of dendritic cells to regulate immunity is dependent on DC maturation. The process of DC maturation, results in an increase in the surface expression of costimulatory molecules, morphological changes (such as formation of dendrites), secretion of chemokines, cytokines and proteases, and surface expression of adhesion molecules and chemokine receptors ...
GcMAF is a natural, immune stimulating protein in all healthy people. But, cancer patients need to learn about a degrading enzyme that inhibits GcMAF.
Hayashi A, Popovich KS, Kim HC, de Juan E (1997). "Role of protein tyrosine phosphorylation in rat corneal neovascularization ...
... such as corneal neovascularization. "International Nonproprietary Names for Pharmaceutical Substances (INN). Recommended ... "NK1 receptor antagonists as a new treatment for corneal neovascularization". Investigative Ophthalmology & Visual Science. 55 ( ...
"NK1 receptor antagonists as a new treatment for corneal neovascularization". Investigative Ophthalmology & Visual Science. 55 ( ... has however continued to be researched for other possible applications such as treatment of corneal neovascularization. ...
Besides, reduced tearing with erosion and neovascularization of the cornea leads to corneal opacification and perforation. ...
The sign is an indication of interstitial (or parenchymatous) keratitis, causing corneal neovascularisation. Blood vessels ...
This result suggests that EP4 activation contributes to corneal neovascularization and that EP4 antagonists may be useful for ... A selective EP4 antagonists significantly reduced corneal neovascularization in rats caused by oxygen-induced retinopathy or ... corneal endothelium, corneal keratocytes, trabecular cells, ciliary epithelium, conjunctival stromal cells, and iridal stromal ...
... and neovascularization have occurred. In these severe and infrequent cases, corneal transplantation has been used as a ... In rare cases of extreme ocular exposure to mustard gas vapors, corneal ulceration, anterior chamber scarring, ...
... corneal neovascularization, and ulceration. Patients with an inflammatory eyelid lesion that appears suspicious of malignancy ... This serves as a primary indication of regional dryness in the pre-corneal tear film after fluorescein injections. If TBUT is ... Other signs may include telangiectasia on the anterior eyelid, collarettes encircling the lash base, and corneal changes. ... and corneal ulcer or irritation. The lids may become red and may have ulcerate, non-healing areas that may lead to bleeding. ...
... sometimes resulting in corneal neovascularization-the growth of blood vessels into the cornea. This causes a slight lengthening ... Both the depth of the corneal incisions and the degree of central corneal flattening correlated with the laser energy applied. ... Those with Fuchs' corneal endothelial dystrophy, corneal epithelial basement membrane dystrophy, retinal tears, autoimmune ... are made of materials with greater oxygen permeability that help reduce the risk of corneal neovascularization, patients ...
Corneal neovascularization (H18.5) Fuchs' dystrophy - cloudy morning vision (H18.6) Keratoconus - degenerative disease: the ... Corneal ulcer / Corneal abrasion - loss of the surface epithelial layer of the eye's cornea (H16.1) Snow blindness / Arc eye - ... a rare congenital eye condition leading to underdevelopment or even absence of the iris of the eye Endophthalmitis Corneal ...
Her research includes the study of The inhibition effect of propranolol on the corneal neovascularization in an alkali-induced ...
Interstitial and deep keratitis 370.6 Corneal neovascularization 370.8 Other forms of keratitis 370.9 Unspecified 371 Corneal ... cornea 371.0 Corneal scars and opacities 371.1 Corneal pigmentations and deposits 371.2 Corneal oedema 371.3 Changes of corneal ... membranes 371.4 Corneal degenerations 371.5 Hereditary corneal dystrophies 371.6 Keratoconus 371.7 Other corneal deformities ... one eye 369.9 Unspecified visual loss 370 Keratitis 370.0 Corneal ulcer 370.1* Dendritic keratitis (054.4†) 370.2 Other ...
In mice models of stromal keratitis and corneal neovascularization (HSV ocular disease), a small RNR2 C-terminal analog BILD ...
... in progressive corneal neovascularisation in patients suffering from infectious keratitis and on the waiting list for Corneal ... including progressive corneal neovascularization in patients suffering from infectious keratitis and wet age related macular ... "GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial" ... "Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascularization and reduce need for ...
... corneal edema MeSH C11.204.290 - corneal neovascularization MeSH C11.204.299 - corneal opacity MeSH C11.204.299.070 - arcus ... corneal ulcer MeSH C11.294.354 - eye infections, bacterial MeSH C11.294.354.220 - conjunctivitis, bacterial MeSH C11.294. ... corneal dystrophies, hereditary MeSH C11.270.162.438 - Fuchs' endothelial dystrophy MeSH C11.270.235 - duane retraction ... retinal neovascularization MeSH C11.768.740 - retinal perforations MeSH C11.768.757 - retinal vasculitis MeSH C11.768.760 - ...
... has potent angiogenic activity upon endothelial cells and induces neovascularization, first demonstrated in a corneal ... enhances physiological adaptation of retinal vessels and reduces pathological neovascularization associated with ischemic ...
Choroidal neovascularization Corneal neovascularization Revascularization Rubeosis iridis Inosculation Neely, Kimberly A.; ... Corneal neovascularization is a condition where new blood vessels invade into the cornea from the limbus. It is triggered when ... Neovascularization in the eye can cause a type of glaucoma (neovascularization glaucoma) if the new blood vessels' bulk blocks ... "Treatment of Corneal Neovascularization". EyeNet Magazine. American Academy of Ophthalmology: 35-6. Retrieved 14 July 2020. ...
... (CNV) is the in-growth of new blood vessels from the pericorneal plexus into avascular corneal ... If the cornea is inflamed via corneal neovascularization, the suppression of enzymes can block CNV by compromising with corneal ... Maintaining avascularity of the corneal stroma is an important aspect of corneal pathophysiology as it is required for corneal ... Treatments for corneal neovascularization are predominately off-lab with a multitude of complications as a result. The desired ...
... choroidal neovascularization) CNV (corneal neovascularization) NVD (neovascularization of the disc) "rubeosis iridis" at ... Once the neovascularization has been longstanding, the new vessels recruit fibrous tissue, and as this forms and contracts, the ... If caught early, the neovascularization can be reversed with prompt pan retinal photocoagulation (PRP), or injection of anti- ... formed by neovascularization) are found on the surface of the iris. This condition is often associated with diabetes in ...
Corneal epithelial infiltrates Keratitis Corneal ulcer Corneal stroma Corneal neovascularisation Corneal oedema Corneal ... Ptosis Giant papillary conjunctivitis Superior limbic keratoconjunctivitis Epithelium Corneal abrasion Corneal erosion Contact ... infiltrates Corneal endothelium Endothelial polymegathism Effects of long-term contact lens wear on the cornea. ...
Untreated cases may develop corneal ulceration, which may perforate resulting in corneal opacification and Staphyloma formation ... Corneal involvement (rare) may occur in herpes simplex ophthalmia neonatorum.. Time of onset[edit]. Chemical causes: Right ...
Copper deposition on corneal Descemet's membrane. The rings, which consist of copper deposits where the cornea meets the sclera ...
Keratoconjunctivitis is the combination of conjunctivitis and keratitis (corneal inflammation). Blepharokeratoconjunctivitis is ...
"Bietti's tapetoretinal degeneration with marginal corneal dystrophy crystalline retinopathy". Trans Am Ophthalmol Soc. 75: 164 ...
Corneal opacity. *Corneal neovascularization. *Kayser-Fleischer ring. *Haab's striae. *Arcus senilis. *Band keratopathy ...
Corneal ectasia *Keratoconus. *Pellucid marginal degeneration. *Keratoglobus. *Terrien's marginal degeneration. *Post-LASIK ...
Corneal ectasia *Keratoconus. *Pellucid marginal degeneration. *Keratoglobus. *Terrien's marginal degeneration. *Post-LASIK ...
Corneal neovascularization. *Kayser-Fleischer ring. *Haab's striae. *Arcus senilis. *Band keratopathy. Vascular tunic. ...
Corneal ectasia *Keratoconus. *Pellucid marginal degeneration. *Keratoglobus. *Terrien's marginal degeneration. *Post-LASIK ...
Corneal ectasia *Keratoconus. *Pellucid marginal degeneration. *Keratoglobus. *Terrien's marginal degeneration. *Post-LASIK ...
Corneal neovascularization. *Kayser-Fleischer ring. *Haab's striae. *Arcus senilis. *Band keratopathy. Vascular tunic. ...
Corneal stromal dystrophies - Macular corneal dystrophy is manifested by a progressive dense cloudiness of the entire corneal ... The hallmark of Schnyder corneal dystrophy is the accumulation of crystals within the corneal stroma which cause corneal ... In the past, the designation vortex corneal dystrophy (corneal verticillata) was applied to a corneal disorder characterized by ... Posterior corneal dystrophies - Fuchs corneal dystrophy presents during the fifth or sixth decade of life. The characteristic ...
... induced apoptosis is necessary for corneal allograft survival". 》Journal of Clinical Investigation》 99 (3): 396-402. PMID ... Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization. Invest ... "Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants". 》Transplantation》 64 (8): ...
Done Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia PMID 27977064 ... Toric intraocular lens versus limbal relaxing incisions for corneal astigmatism after phacoemulsification PMID 31845757 https ... Done Oral antivirals for preventing recurrent herpes simplex keratitis in people with corneal grafts PMID 27902849 https://doi. ... Done Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty PMID 26313245 https://doi ...
Corneal neovascularization. * Kayser-Fleischer ring. * Arcus senilis. * Band keratopathy. Vascular tunic. عنبیه و جسم مژگانی. * ...
Corneal neovascularization. *Kayser-Fleischer ring. *Haab's striae. *Arcus senilis. *Band keratopathy. Vascular tunic. ...
Photorefractive keratectomy (PRK) involves ablation of corneal tissue from the corneal surface using an excimer laser. The ... a corneal flap is cut into the cornea and lifted to allow the excimer laser beam access to the exposed corneal tissue. After ... When the flap again covers the cornea, the change in curvature generated by the laser ablation proceeds to the corneal surface ... Pallikaris IG, Kymionis GD, Astyrakakis NI (2001). "Corneal ectasia induced by laser in situ keratomileusis". J Cataract ...
Micrograph of a chronic subdural hematoma, as demonstrated by thin strands of collagen and neovascularization. HPS stain ...
Choroidal neovascularization. *City university test. *Cochrane Eyes and Vision. *Community ophthalmic physician ... Corneal opacity. *Corneal topography. *Corrective lens. *Cover test. *Cup-to-disc ratio ...
Corneal ectasia *Keratoconus. *Pellucid marginal degeneration. *Keratoglobus. *Terrien's marginal degeneration. *Post-LASIK ...
"Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to ocular ... Corneal ectasia *Keratoconus. *Pellucid marginal degeneration. *Keratoglobus. *Terrien's marginal degeneration. *Post-LASIK ... "Intravitreal bevacizumab for choroidal neovascularization secondary to presumed ocular histoplasmosis syndrome". Retina ( ... and a maculopathy caused by choroidal neovascularization. ... of vision in POHS is caused by choroidal neovascularization. ...
... corneal ulcers and corneal neovascularization-this latter condition, once it sets in, cannot be reversed and will eventually ... corneal abrasions and erosion, keratitis, corneal edema, descemetocele, corneal ectasis, Mooren's ulcer, anterior corneal ... "The Corneal Lens", The Optician, 2 September 1949, pp. 141-144. *^ "Corneal Contact Lenses", The Optician, 9 September 1949, p ... The most prominent risks associated with long-term, chronic low oxygen to the cornea include corneal neovascularization, ...
Corneal ectasia *Keratoconus. *Pellucid marginal degeneration. *Keratoglobus. *Terrien's marginal degeneration. *Post-LASIK ...
Corneal ectasia *Keratoconus. *Pellucid marginal degeneration. *Keratoglobus. *Terrien's marginal degeneration. *Post-LASIK ...
Corneal collagen cross-linking[edit]. Main article: Corneal collagen cross-linking. There is evidence suggesting corneal ... The gold standard diagnostic test for PMD is corneal topography.[2] However, it may not as specific as corneal pachymetry, ... PMD lacks apical corneal scarring, Rizutti's phenomenon, Munson's sign, and the central corneal thickness is usually normal.[2] ... Corneal ectatic disorders. References[edit]. *^ a b c Karim Rasheed, MD (2005). "Pellucid Marginal Degeneration". WebMD. ...
VSX1 Corneal dystrophy, lattice type I; 122200; TGFBI Corneal dystrophy, lattice type IIIA; 608471; TGFBI Corneal dystrophy, ... with choroidal neovascularization; 608161; PRPH2 Fragile X syndrome; 300624; FMR1 Fragile X tremor/ataxia syndrome; 300623; ... ZEB1 Corneal dystrophy, gelatinous drop-like; 204870; TACSTD2 Corneal dystrophy, Groenouw type I; 121900; TGFBI Corneal ... TGFBI Corneal dystrophy, Thiel-Behnke type; 602082; TGFBI Corneal endothelial dystrophy 2; 217700; SLC4A11 Corneal endothelial ...
Neovascularisation (growth of new abnormal vessels) is possible and any eye surgery, such as cataract surgery, can cause ... and keratitic precipitates on the posterior corneal surface. Patients are often asymptomatic and the disease is often ...
Corneal neovascularization (CNV) is the in-growth of new blood vessels from the pericorneal plexus into avascular corneal ... If the cornea is inflamed via corneal neovascularization, the suppression of enzymes can block CNV by compromising with corneal ... Maintaining avascularity of the corneal stroma is an important aspect of corneal pathophysiology as it is required for corneal ... Treatments for corneal neovascularization are predominately off-lab with a multitude of complications as a result. The desired ...
All patients suffered from some form of corneal neovascularization (NV). Patients in group A received 0.2-0.5 mL of bevacizumab ... The use of bevacizumab seems to be an effective and safe method in the treatment of corneal neovascularization, either in the ... in patients with corneal neovascularization. ,i,Methods,/i,. Patients were divided into two groups. ... We evaluated the number of corneal segments affected by NV, CDVA, and the incidence of complications and subjective complaints ...
This prospective study quantified changes in corneal neovascularization in patients with active keratitis after treatment using ... of corneal neovascularization and should be considered in studies in which assessment of corneal neovascularization is needed. ... A comparison of corneal neovascularization parameters was undertaken before and after resolution of keratitis. A slit-lamp ... This prospective study quantified changes in corneal neovascularization in patients with active keratitis after treatment using ...
In summary, corneal neovascularization occurs soon after the onset of corneal infection by C. albicans. Angiogenesis ... Corneal neovascularization. Curr Opin Ophthalmol. 2001; 12:242-9. [PMID: 11507336] * Azar DT. Corneal angiogenic privilege: ... Purpose: To investigate the development of corneal neovascularization, the corneal expression of vascular endothelial growth ... Corneal neovascularization occurs in response to angiogenic mediators released by leukocytes and corneal cells [15,16]. ...
Ten eyes of 9 patients with corneal NV received topical ranib ... the effect of topical ranibizumab on clinically stable corneal ... neovascularization (NV). This was a prospective, open-label, monocentric, uncontrolled noncomparative study. ... Corneal Neovascularization / drug therapy*, physiopathology. Female. Humans. Intraocular Pressure / physiology. Male. Middle ... PURPOSE: To examine the effect of topical ranibizumab on clinically stable corneal neovascularization (NV).. METHODS: This was ...
Researchers randomized 24 rats with cauterization-induced corneal inflammatory angiogenesis to a week of daily injection with ... The corneal neovascularization surface was significantly reduced in the dexamethasone, bevacizumab 5.0 mg/day, and ... with dexamethasone caused a significant reduction in corneal opacity and in the surface of corneal neovascularization compared ... Researchers randomized 24 rats with cauterization-induced corneal inflammatory angiogenesis to a week of daily injection with ...
... corneal collagen cross-linking, CXL) on corneal neovascularization (CNV) in a rabbit alkali burn model. ,i,Methods,/i,. A total ... CNV area, corneal edema, and corneal epithelial defects were observed on days 4, 7, 10, and 14 after injury. Western blot was ... i,Results,/i,. CXL treatment decreased CNV and corneal edema in all groups compared to Group A. On day 7, MMP-9 expression was ... i,Conclusions,/i,. Our results indicate that riboflavin-ultraviolet-A-induced cross-linking (corneal collagen cross-linking, ...
Topical IL-1-Ra for Treatment of Corneal Neovascularization. This study has been terminated. ... This is a single site, randomized, double masked, crossover, phase I/II study of topical IL-1Ra (5.0%) in subjects with corneal ... Invasion Area (IA), Measuring the Fraction of the Total Corneal Area Invaded by the Vessels [ Time Frame: 64 Weeks ]. ... Vessel Caliber (VC), Measuring the Mean Diameter of the Corneal Vessels [ Time Frame: 64 Weeks ]. ...
Corneal Neovascularization. Neovascularization, Pathologic. Metaplasia. Pathologic Processes. Corneal Diseases. Eye Diseases. ... and the loss of the limbal stem cell barrier can cause corneal neovascularization. Growth of new vessels may result in corneal ... Topical IL-1-Ra for Treatment of Corneal Neovascularization. The safety and scientific validity of this study is the ... Central Corneal Thickness [ Time Frame: 64 Weeks ]. The Principal Investigator decided to terminate the study and stop ...
... noncomparative study included 10 eyes of nine patients with corneal neovascularization. Lucentis (ranibizumab 1%, Genentech) ... Corneal neovascularization may be treated with topical ranibizumab to reduce severity through decrease in the vessel caliber, ...
The authors describe a patient with lipid keratopathy secondary to corneal neovascularization treated with photodynamic therapy ... Six months following treatment the neovascularization has not returned and the lipid keratopathy has not increased in size. No ... Corneal neovascularization can be a difficult problem to treat. ... Corneal neovascularization can be a difficult problem to treat ... Corneal neovascularization following keratitis can be a problem affecting vision that is difficult to treat and many different ...
Neovascularization in the superficial and/or deep corneal stroma is a sequel to numerous inflammatory diseases of the ocular ... New blood vessels originating from the corneal veins and extending from the limbus into the adjacent CORNEAL STROMA. ... and the immune response elicited by CORNEAL TRANSPLANTATION. ... Neovascularization in the superficial and/or deep corneal ... Angiogenesis, Corneal; Corneal Neovascularizations; Neovascularization, Corneal; Neovascularizations, Corneal; Corneal ...
Subconjunctival Suramab Inhibits Corneal Neovascularization You will receive an email whenever this article is corrected, ... Conclusions: : Intravenous and subconjuntival Suramab reduced corneal neovascularization, but the duration of the effect was ... The present study aims to evaluate the effect of subconjuntival Suramab on corneal neovascularization. ... E. S. Lopez, A. Kvanta,, J. Croxatto, J. Gallo; Subconjunctival Suramab Inhibits Corneal Neovascularization. Invest. Ophthalmol ...
Corneal neovascularization was observed under a slit lamp microscope and evaluated via immunohistochemistry. The cells that ... Keratocytes create stromal spaces to promote corneal neovascularization via MMP13 expression.. [Jing Ma, Dan Zhou, Meihua Fan, ... To investigate the exact mechanism by which keratocytes promote corneal neovascularization. The expression of matrix ... Keratocytes could directly degrade type I collagen and create stromal spaces, promoting corneal neovascularization through ...
S100A proteins in the pathogenesis of experimental corneal neovascularization.. Li C1, Zhang F, Wang Y. ... Suture-induced neovascularization and infiltration in murine corneas. The disease scores provided correspond to each time point ... in mice was performed to evaluate the role of neutrophils and S100A proteins in suture-induced corneal neovascularization (S- ... study examines whether S100A proteins are involved in the pathogenesis of inflammation-associated corneal neovascularization ( ...
Corneal neovascularization (corneal NV) is a central feature in the pathogenesis of many blinding corneal disorders and is also ... Inhibition of corneal neovascularization with endostatin delivered by adeno-associated viral (AAV) vector in a mouse corneal ... Subconjunctival injection of Bevacizumab (Avastin) inhibits corneal neovascularization in different rabbit models of corneal ... Multi-gene targeted antiangiogenic therapies for experimental corneal neovascularization. Peng Chen,1 Hongmei Yin,1 Yao Wang,1 ...
The heparan sulfate suleparoide inhibits rat corneal angiogenesis and in vitro neovascularization.. [U Benelli, G Bocci, R ... AgNO3/KNO3 injury was used to induce corneal neovascularization and to evaluate the therapeutic effect of topical suleparoide, ... while the involvement of bFGF in angiogenesis was evidenced by immunohistochemistry of corneal tissue. Quantitation of ...
Dexamethasone suppresses HSV-1- induced corneal neovascularization You will receive an email whenever this article is corrected ... Hem Raj Gurung, Daniel J Carr; Dexamethasone suppresses HSV-1- induced corneal neovascularization. Invest. Ophthalmol. Vis. Sci ... Corneal lymphatic vessels (LYVE-1+) and blood vessels (CD31+) were visualized by confocal microscopy following ... Infiltrating leukocyte populations were assessed by flow cytometry of corneal single-cell suspensions. Pro-angiogenic protein ...
Preoperative corneal neovascularization (CNV) is thought to be associated with an increased rate of corneal graft failure and ... Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis ... Graft failure and rejection risk increase with an increasing number of corneal quadrants affected by neovascularization before ... Electronic databases and corneal registries were searched (up through September 2008). Results were reported both descriptively ...
Then, 1 μg of p-bFGF-SAINT-18 was prepared and implanted into the rat corneal stroma 1.5 mm from the limbus on the same side. ... Then, 1 μgof p-bFGF-SAINT-18 was prepared and implanted into the rat corneal stroma 1.5 mm fromthe limbus on the same side. The ... Subconjunctival injection with the combination of bevacizumab and p-PEDF-SAINT-18 successfully inhibited corneal NV. The bFGF ... Subconjunctival injection with thecombination of bevacizumab and p-PEDF-SAINT-18 successfully inhibited corneal NV.The bFGF and ...
... ... "Potential role of corneal epithelial cell-derived exosomes in corneal wound healing and neovascularization." Scientific Reports ... These findings demonstrate that epithelial-derived exosomes may be involved in corneal wound healing and neovascularization, ... Our results indicate that epithelial cell-derived exosomes mediate communication between corneal epithelial cells and corneal ...
View Corneal Neovascularisation Dexagel side effect risks. Female, 39 years of age, was diagnosed with keratitis and took ... Is Corneal Neovascularisation a common side effect of Dexagel? ... This Corneal Neovascularisation side effect was reported by a ... Corneal Deposits, Corneal Erosion, Corneal Neovascularisation, Corneal Perforation, Corneal Transplant, Impaired Healing, ... Dexagel Corneal Neovascularisation Side Effect Reports. Home → Dexagel → Corneal Neovascularisation The following Dexagel ...
Corneal neovascularization (CNV) is one of the leading risk factors for vision loss. Anti-angiogenic drugs can theoretically be ... Corneal neovascularization (CNV) is one of the leading risk factors for vision loss. Anti-angiogenic drugs can theoretically be ... of mucoadhesive cationic polypeptide micelles for sustained cabozantinib release and inhibition of corneal neovascularization ... The Cabo-NPs possessed good biocompatibility both in corneal epithelial cells and mouse corneas. More importantly, in vitro ...
Corneal Neovascularization - Pipeline Review, H2 2017, provides an overview of the Corneal Neovascularization ... Home / Ophthalmology / Corneal Neovascularization - Pipeline Review, H2 2017. Corneal Neovascularization - Pipeline Review, H2 ... Corneal Neovascularization - Pipeline by EyeGate Pharmaceuticals Inc, H2 2017. Corneal Neovascularization - Pipeline by Gene ... Corneal Neovascularization - Overview. Corneal Neovascularization - Therapeutics Development. Pipeline Overview. Pipeline by ...
Further, to evaluate the effect of ANG2 inhibition on corneal neovascularisation (CNV). ... Angiopoietin 2 expression in the cornea and its control of corneal neovascularisation ... Angiopoietin 2 expression in the cornea and its control of corneal neovascularisation ... In another set of experiments, the corneal basal Bowman membrane was either (i) removed or (ii) left in place. After 2 or 10 ...
Michels, R; Michels, S; Kaminski, S (2012). Effect of combined topical heparin and steroid on corneal neovascularization in ... Download PDF Effect of combined topical heparin and steroid on corneal neovascularization in children. Item availability may ... Effect of combined topical heparin and steroid on corneal neovascularization in children ... To demonstrate the effect of topical heparin combined with topical steroid on corneal neovascularization (CN) in children. ...
Review of the Progress in Corneal Neovascularization Animal Models Shuci Tian1, Shurong Wang1, Yuxi He2, Xin Liu1, Ying Li1, ... Corneal Neovascularization (CNV), the extensive growth of blood vessels from conjunctiva into the cornea. It is a sight- ... Review of the Progress in Corneal Neovascularization Animal Models. American Journal of Biochemistry and Biotechnology, 11(4), ... Abnormal angiogenesis plays an important role in the process of CNV, which may result from corneal wound healing. Neovascular ...
Bar ⫽ 500 ␮m. Corneal angiogenesis assay. Seven days after corneal implantation of discs, neovascularization extending from the ... Corneal implant angiogenesis assay. The vascular growth factor-induced corneal neovascularization bioassay was performed in ... models of corneal neovascularization, and anti- INHIBITION OF IL-1, NOT TNF, SUPPRESSES NEOVASCULARIZATION TNF␣ therapy ... adjuvant, angiogenesis, corneal, suppressor, inhibition, rat, necrosis, factors, model, arthritis, neovascularization, ...
Long non-coding RNA H19 promotes corneal neovascularization by targeting microRNA-29c. Baoqi Sun, Yiheng Ding, Xin Jin, Shuo Xu ... 2012) Corneal neovascularization: an anti-VEGF therapy review. Surv. Ophthalmol. 57, 415-429 doi:10.1016/j.survophthal.2012.01. ... 2013) Corneal neovascularization: a review of the molecular biology and current therapies. Expert Rev. Ophthalmol. 8, 167-189 ... 2001) Corneal neovascularization. Curr. Opin. Ophthalmol. 12, 242-249 doi:10.1097/00055735-200108000-00002 pmid:11507336. ...
Corneal Neovascularization and Wound Healing. Corneal Neovascularization. Corneal neovascularization (NV) is characterized by ... Corneal Wound Healing. Corneal injuries are common in both men and women across all age groups and are among the most common ... We also offer an in vitro corneal wound healing model that utilizes primary murine or human corneal epithelial cells. These ... For this model, an Algerbrush II with a 0.5mm Burr or a dulled blade is used to remove the corneal epithelial layer. The speed ...
  • Since the year 1872, when Arnold demonstrated that the process of angiogenesis utilizes the striae of intracellular cement for neovascularization (NV) formation in the cornea [ 1 ], the results of new research examining the process of new vessel formation in the cornea have been published [ 2 , 3 ]. (hindawi.com)
  • Corneal neovascularization complicates Candida albicans keratitis [ 6 ], but the molecular pathogenesis of angiogenesis during fungal keratitis has not yet been studied. (molvis.org)
  • Other angiogenesis or anti-angiogenesis pathways are also important in the development of neovascularization. (molvis.org)
  • The heparan sulfate suleparoide inhibits rat corneal angiogenesis and in vitro neovascularization. (sigmaaldrich.com)
  • AgNO3/KNO3 injury was used to induce corneal neovascularization and to evaluate the therapeutic effect of topical suleparoide, while the involvement of bFGF in angiogenesis was evidenced by immunohistochemistry of corneal tissue. (sigmaaldrich.com)
  • Given that exosomes are known to transfer bioactive molecules among cells and play crucial roles in wound healing, angiogenesis, and cancer, we hypothesized that corneal epithelial cell-derived exosomes may gain access to the underlying stromal fibroblasts upon disruption of the epithelial basement membrane and that they induce signaling events essential for corneal wound healing. (harvard.edu)
  • Abnormal angiogenesis plays an important role in the process of CNV, which may result from corneal wound healing. (thescipub.com)
  • Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis. (docme.ru)
  • A corneal angiogenesis assay was performed by implanting nylon discs impregnated with an angiogenic stimulator (basic fibroblast growth factor or vascular endothelial growth factor) into one cornea of female Sprague-Dawley rats. (docme.ru)
  • Treatment with IL-1Ra yielded a dosedependent reduction in growth factor-induced corneal angiogenesis, while PEG sTNFRI did not. (docme.ru)
  • To study the effect of topical administration of a fusion protein (PF-MC) made up of N-terminal portion of the protease inhibitor Trappin-2 (which is a substrate of transglutaminasa-2) and SLPI (protein with anti-inflammatory, anti-bacterial and anti-viral ability), in an animal model of corneal inflammation and angiogenesis. (biomedcentral.com)
  • The binding of SLPI with Cementoin to transglutaminase seems to be an effective strategy to treat corneal inflammation and angiogenesis. (biomedcentral.com)
  • A PubMed review was performed, analysing all publications from 1968 to 2017 concerning the topic "corneal neovascularization" (keywords: cornea, new vessels, neovascularization, and angiogenesis). (biomedcentral.com)
  • Neovascularization (or angiogenesis) is a process whereby new blood vessels are formed within tissues of the body. (google.com.au)
  • 2) To delineate the difference of slow released nanomedicine for the anti-angiogenesis inhibition and it mechanism in vitro and (3) To elucidate the therapeutic efficiency by topical delivery (eyedrop) in a mice/rabbit model with corneal neovascular ingrowth. (elsevier.com)
  • There are three different pathways that comprise neovascularization:(1) vasculogenesis,(2) angiogenesis, and (3) arteriogenesis. (wikipedia.org)
  • Angiogenesis is the most common type of neovascularization seen in development and growth, and is import to both physiological and pathological processes. (wikipedia.org)
  • Corneal infiltrating neutrophils were shown to express MMP-9, and preventing the neutrophil response with specific mAb diminished MMP-9 expression as well as the extent of angiogenesis. (jci.org)
  • Further supporting a role for MMP-9 in HSV-induced corneal angiogenesis was the observation that inhibition of MMP-9 with the specific inhibitor TIMP-1 resulted in reduced angiogenesis. (jci.org)
  • Currently, the mechanisms by which HSV infection results in corneal angiogenesis remain ill-defined, and more than likely multiple participants could be involved. (jci.org)
  • To extend our understanding of the proatherogenic role of Sema7A, we investigated the role of endothelial Sema7A in angiogenesis and atherosclerotic neovascularization. (frontiersin.org)
  • The accumulated evidence has confirmed the importance of angiogenesis and validated the theory that inhibition of neovascularization is a promising anticancer strategy ( 11 - 13 ). (aacrjournals.org)
  • reported that thymoquinone showed inhibitory effects on corneal neovascularization in the rat model ( 14 ), whether thymoquinone inhibits tumor angiogenesis and suppresses prostate tumor growth through tumor angiogenesis prevention is still not fully understood. (aacrjournals.org)
  • Corneal neovascularization (CNV) is the in-growth of new blood vessels from the pericorneal plexus into avascular corneal tissue as a result of oxygen deprivation. (wikipedia.org)
  • 0.01) decreased the formation of new corneal blood vessels during experimental keratomycosis without adversely affecting the fungal load of C. albicans keratitis. (molvis.org)
  • The purpose of this study is to determine the effectiveness and safety of Interleukin-1-Receptor Antagonist eye drops for the treatment of corneal blood vessels. (clinicaltrials.gov)
  • New blood vessels originating from the corneal veins and extending from the limbus into the adjacent CORNEAL STROMA. (curehunter.com)
  • Corneal lymphatic vessels (LYVE-1+) and blood vessels (CD31+) were visualized by confocal microscopy following immunohistochemical staining. (arvojournals.org)
  • Corneal Neovascularization (CNV), the extensive growth of blood vessels from conjunctiva into the cornea. (thescipub.com)
  • 2604 INHIBITION OF IL-1, NOT TNF, SUPPRESSES NEOVASCULARIZATION endothelial cells in newly formed blood vessels as direct participants in the bone erosion by pannus. (docme.ru)
  • Corneal neovascularization (NV) is characterized by the growth of new blood vessels into the normally avascular cornea. (eyecro.com)
  • The primary endpoint was measured by the reduction in area covered by pathologic corneal blood vessels measured morphometrically on digitized slit-lamp pictures. (eyedocnews.com)
  • Normal neovascularization is the physiological process by which the body creates and maintains small blood vessels of the circulatory system. (google.com.au)
  • However, pathological or latrogenic neovascularization is a non-physiological process whereby abnormal networks of blood vessels are created in tissues of the body or in tumors, as a result of certain diseases, trauma or surgical procedures. (google.com.au)
  • The two procedures using bevacizumab were compared with instillation and subconjunctival injection of saline solution (S). Neovascularization was evaluated according to the size of the invasion area of new blood vessels and through computerized analysis of this area. (bvsalud.org)
  • Neovascularization is the natural formation of new blood vessels (neo- + vascular + -ization), usually in the form of functional microvascular networks, capable of perfusion by red blood cells, that form to serve as collateral circulation in response to local poor perfusion or ischemia. (wikipedia.org)
  • Corneal neovascularization is a condition where new blood vessels invade into the cornea from the limbus. (wikipedia.org)
  • The immature new blood vessels can lead to persistent inflammation and scaring, lipid exudation into the corneal tissues, and a reduction in corneal transparency, which can affect visual acuity. (wikipedia.org)
  • Neovascularization in the eye can cause a type of glaucoma (neovascularization glaucoma) if the new blood vessels' bulk blocks the constant outflow of aqueous humour from inside the eye. (wikipedia.org)
  • is characterized by the proliferation of multiple small blood vessels in the corneal stroma. (nih.gov)
  • choroidal neovascularization (CNV) Abnormal growth of blood vessels, originating in the choriocapillaris, which pass through Bruch's membrane and then proliferate under the retinal pigment epithelium (type 1) and/or under the retina (type 2). (thefreedictionary.com)
  • iris neovascularization Abnormal formation of new blood vessels on the anterior surface of the iris. (thefreedictionary.com)
  • The deposition of flaky, translucent fibrillar material most conspicuous on the anterior lens capsule and pupillary margin but also in both surfaces of the iris, the zonules, trabecular meshwork, ciliary body, corneal endothelium, and orbital blood vessels. (bioportfolio.com)
  • Maintaining avascularity of the corneal stroma is an important aspect of corneal pathophysiology as it is required for corneal transparency and optimal vision. (wikipedia.org)
  • Neovascularization in the superficial and/or deep corneal stroma is a sequel to numerous inflammatory diseases of the ocular anterior segment, such as TRACHOMA, viral interstitial KERATITIS, microbial KERATOCONJUNCTIVITIS, and the immune response elicited by CORNEAL TRANSPLANTATION. (curehunter.com)
  • At different time points after suturing, we conducted histopathological examinations to detect the infiltration of inflammatory cells into the corneal stroma. (nih.gov)
  • Then, 1 μg of p-bFGF-SAINT-18 was prepared and implanted into the rat corneal stroma 1.5 mm from the limbus on the same side. (mdpi.com)
  • In the present study, exosome-like vesicles were observed between corneal epithelial cells and the stroma during wound healing after corneal epithelial debridement. (harvard.edu)
  • Disruption of the Bowman membrane is associated with a significant increase of (i) ANG2 stromal expression and (ii) proangiogenic macrophage infiltration in the corneal stroma. (bmj.com)
  • In this group there was a reduced number of PMNs in the corneal stroma at 3 and 7 days of follow-up. (biomedcentral.com)
  • The corneal stroma is normally avascular, but damage from various causes may result in neovascularization. (nih.gov)
  • This enzyme was shown to contribute to the neovascularization process that occurs in the corneal stroma in response to HSV infection. (jci.org)
  • One of the more distressing lesions caused by herpes simplex virus (HSV) infection is vision impairment and blindness resulting from a chronic immunoinflammatory reaction in the corneal stroma. (jci.org)
  • One early essential event appears to be neovascularization of the normally avascular corneal stroma. (jci.org)
  • To evaluate antiangiogenic effect of local use of bevacizumab (anti-VEGF antibody) in patients with corneal neovascularization. (hindawi.com)
  • The use of bevacizumab seems to be an effective and safe method in the treatment of corneal neovascularization, either in the subconjunctival or topical application form. (hindawi.com)
  • Bevacizumab as monotherapy or in combination with dexamethasone caused a significant reduction in corneal opacity and in the surface of corneal neovascularization compared with the control group. (aao.org)
  • The corneal neovascularization surface was significantly reduced in the dexamethasone, bevacizumab 5.0 mg/day, and dexamethasone plus bevacizumab groups compared with the control group (P = 0.045, 0.047, and 0.044, respectively). (aao.org)
  • In this study, we demonstrated that the combination of bevacizumab and plasmid pigment epithelium-derived factor-synthetic amphiphile INTeraction-18 (p-PEDF-SAINT-18) has a favorable antiangiogenic effect on corneal NV. (mdpi.com)
  • Subconjunctival injection with the combination of bevacizumab and p-PEDF-SAINT-18 successfully inhibited corneal NV. (mdpi.com)
  • Corneal Fine Needle Diathermy With Adjuvant Bevacizumab to Treat Corneal Neovascularization in Children. (semanticscholar.org)
  • PURPOSE To report the outcomes of corneal fine needle diathermy (FND) with adjuvant intrastromal and subconjunctival bevacizumab injection for corneal neovascularization (CN) in children. (semanticscholar.org)
  • CONCLUSIONS Corneal FND with adjuvant bevacizumab injection is effective at treating sectorial corneal vessels in children. (semanticscholar.org)
  • Efficacy of subconjunctival bevacizumab injection in corneal neovascularisation. (bvsalud.org)
  • Subconjunctival injection of Bevacizumab ( Avastin ) caused significant regression of corneal neovascularisation in 1 pt, partial regression in 6 pts and no effect in 3 pts as measured by length and surface area of neovascularisation. (bvsalud.org)
  • of Bevacizumab is effective in regressing corneal neovascularisation. (bvsalud.org)
  • Objectives To study the safety and efficacy of topical bevacizumab in the treatment of corneal neovascularization (NV). (harvard.edu)
  • To evaluate and compare the effects of topical application and subconjunctival injection of bevacizumab on corneal neovascularization (CNV) in rabbits ' eyes after chemical burning of the cornea . (bvsalud.org)
  • To describe a potential complication during intrastromal injection of Bevacizumab in a patient with lipoid deposition secondary to corneal neovascularization. (escrs.org)
  • Bevacizumab may be a good option for treating lipoid deposits and corneal neovascularization as metaherpetic sequelae. (escrs.org)
  • Inhibition of corneal neovascularization after alkali burn: Comparison of different doses of bevacizumab in monotherapy or associated with dexamethasone. (nih.gov)
  • A single dose of 1.25 mg (0.05 ml) of bevacizumab was injected into the subconjunctival area 1-2 mm behind the limbus near the corneal NV. (ispub.com)
  • Pattern electroretinographic results after photodynamic therapy alone and photodynamic therapy in combination with intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration. (ebscohost.com)
  • Abstract  Purpose To evaluate the changes in pattern electroretinography (PERG) 1 month after photodynamic therapy alone and photodynamic therapy in combination with intravitreal bevacizumab for choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD). (ebscohost.com)
  • Corneal neovascularization is a sight-threatening condition that can be caused by inflammation related to infection, chemical injury, autoimmune conditions, immune hypersensitivity, post-corneal transplantation, and traumatic conditions among other ocular pathologies. (wikipedia.org)
  • Common available therapy is limited to removing the primary cause of new vessel formation in the cornea, local application of corticosteroids, laser photocoagulation of bigger vessel strains, and corneal transplantation in extreme cases [ 3 ]. (hindawi.com)
  • Purpose Each year, over 8,000 corneal transplantation surgeries are performed in China. (harvard.edu)
  • Lasik surgery is relatively safe and effective surgery , if you are undergoing such surgery you have to take time , find pros and cons of such procedure and go to the best centers not to the mills, ask the surgeon for possible complications not simple flares , refractive errors , but requiting corneal transplantation , flap problems , infection etc these are rare but can happen. (healthtap.com)
  • This study examines the effect of allergic conjunctivitis, with and without dexamethasone treatment, on the early inflammatory response and lymphangiogenesis in the host cornea following corneal transplantation. (bmj.com)
  • In ophthalmology, choroidal neovascularization is the formation of a microvasculature within the innermost layer of the choroid of the eye. (wikipedia.org)
  • The purpose of this study was to compare optical coherence tomographyangiography (OCTA) and indocyanine green angiography (ICGA) for the assessment ofcorneal neovascularization (CoNV).METHODS. (elsevier.com)
  • PURPOSE:To describe a method to assess corneal neovascular (CoNV) complexes and identify feeder vessels for selective arterial fine-needle diathermy (FND).METHODS:In patients with CoNV, color photography and corneal indocyanine green angiography (ICGA) and fluorescein angiography are performed. (ulster.ac.uk)
  • The methods of cell therapy aimed at the restoration of stem cell pool of corneal tissues are the most promising. (deepdyve.com)
  • Common causes of CNV within the cornea include trachoma, corneal ulcers, phylctenular keratoconjunctivitis, rosacea keratitis, interstitial keratitis, sclerosing keratitis, chemical burns, and wearing contact lenses for over-extended periods of time. (wikipedia.org)
  • This prospective study quantified changes in corneal neovascularization in patients with active keratitis after treatment using color imaging, fluorescein angiography (FA), and indocyanine green angiography (ICGA). (aao.org)
  • A comparison of corneal neovascularization parameters was undertaken before and after resolution of keratitis. (aao.org)
  • Untreated C. albicans keratitis induces VEGF-A and leads to progressive corneal neovascularization that is preventable by a VEGF-blocking antibody. (molvis.org)
  • We used a murine model of posttraumatic C. albicans keratitis to determine the corneal VEGF profile during the onset and progression of fungal keratitis. (molvis.org)
  • Corneal neovascularization following keratitis can be a problem affecting vision that is difficult to treat and many different treatment modalities have been tried over the years. (healio.com)
  • 1 We report a case of corneal neovascularization with lipid keratopathy secondary to Herpes simplex virus (HSV) keratitis where the neovascularization was treated with photodynamic therapy (PDT) and the lipid keratopathy stabilized. (healio.com)
  • A 37-year-old woman developed a right corneal ulcer in January 2000 secondary to HSV keratitis. (healio.com)
  • Pannus or deep stromal neovascularization can be seen in eyes with extended use of contact lens, chronic blepharoconjunctivitis, keratitis, trachoma, toxic chemical injuries, graft rejection and phlyctenulosis. (columbiaeye.org)
  • Three eyes had a history of herpes simplex keratitis (HSK), 3 eyes had complete corneal anesthesia, 2 eyes had CN following suture tract infection after corneal transplant for HSK scar and limbal dermoid excision, and 1 eye had blepharokeratoconjunctivitis. (semanticscholar.org)
  • Neovascularization is a frequent complication of corneal infection, and the prevalence of infectious keratitis reflects a general picture of the extent of corneal neovascularization that occurs worldwide. (biomedcentral.com)
  • 10 patients with severe corneal neovascularisation (5 after corneal transplant and 5 after infectious keratitis). (escrs.org)
  • Collectively, our results indicate that corneal P. aeruginosa infection induces a strong Th17-mediated corneal pathology, and treatment with endogenously derived protein such as Gal-1 may be of therapeutic value for the management of bacterial keratitis, a prevalent cause of vision loss and blindness in humans worldwide. (jimmunol.org)
  • Corneal infection with Pseudomonas aeruginosa is a leading cause of infectious microbial keratitis and associated vision impairment in humans worldwide ( 1 - 3 ). (jimmunol.org)
  • This bacterial keratitis is characterized by rapid inflammatory response with suppurative coagulative necrosis, often irreversibly damaging corneal tissue architecture, leading to vision loss ( 4 ). (jimmunol.org)
  • When ocular inflammation occurs, corneal epithelial and endothelial cells, macrophages and certain inflammatory cells produce angiogenic growth factors, namely vascular endothelial growth factor (VEGF) and fibroblast growth factors. (wikipedia.org)
  • To investigate the development of corneal neovascularization, the corneal expression of vascular endothelial growth factor (VEGF), and the antiangiogenic effects of a VEGF-inhibitory antibody during experimental keratomycosis. (molvis.org)
  • Since increased secretion of vascular endothelial growth factor (VEGF) [ 4 - 6 ] has been observed in corneal NV as well as in other ocular neovascularization, some of the efforts have been directed at blocking VEGF or its endothelial cell-specific receptors, namely vascular endothelial growth factor receptor 1 (Flt-1) and vascular endothelial growth factor receptor 2 (Flk-1). (molvis.org)
  • Our results indicate that epithelial cell-derived exosomes mediate communication between corneal epithelial cells and corneal keratocytes as well as vascular endothelial cells. (harvard.edu)
  • Growth factors that inhibit neovascularization include those that affect endothelial cell division and differentiation. (wikipedia.org)
  • The most common features of this syndrome are the movement of endothelial cells off the cornea onto the iris leading to corneal swelling, distortion of the iris, and variable degrees of distortion of the pupil. (bioportfolio.com)
  • It depends on a multitude of factors such as your best corrected vision , your corneal thickness, your endothelial cell count (health of the inner layer of cells). (healthtap.com)
  • Nitidine chloride dose dependently suppressed VEGF-induced endothelial cell proliferation, migration, and tubular structure formation in vitro and dramatically reduced VEGF-triggered neovascularization in mouse cornea and Matrigel plugs in vivo . (aacrjournals.org)
  • The article discusses a research that suggests that choroidal neovascularization and retinal exudation in patients with choroidal osteoma can be regulated with anti-vascular endothelial growth factor (VEGF) therapy. (ebscohost.com)
  • The article discusses a research study which showed the effectiveness of anti-vascular endothelial growth factor (VEGF) therapy in the treatment of patients with myopic choroidal neovascularization (CNV). (ebscohost.com)
  • The article discusses the role of anti-vascular endothelial growth factor (VEGF) therapy in treatment of corneal neovascularization. (ebscohost.com)
  • Therefore, the public health impact of treatment cornea neovascularization is significant. (elsevier.com)
  • Eye, Cornea - Neovascularization in a male F344/N rat from a chronic study. (nih.gov)
  • Corneal NV is the pathological ingrowth of vessels to the cornea from the limbal vascular plexus. (hindawi.com)
  • Other reasons for the formation of pathological vessels in cornea are corneal infections, trauma, and immunological processes. (hindawi.com)
  • Growth of new vessels may result in corneal scarring, edema, lipid deposition, and inflammation that may alter visual acuity and is a leading cause of monocular visual impairment and blindness. (clinicaltrials.gov)
  • This increased to 3.3 mm diameter by November 2006 and argon laser of the corneal vessels during fluorescein infusion was attempted twice with no effect. (healio.com)
  • New therapeutic options that offer differential influence on the ingrowths or regression of either corneal blood or lymphatic vessels force us to re-evaluate the known data about the role of CNV in keratoplasty. (nih.gov)
  • Diathermy of large feeding vessels and corneal laser photocoagulation has been among the surgical modalities to treat pannus. (columbiaeye.org)
  • ICGA allows the identification and delineation of afferent feeder vessels even in the presence of corneal opacities affecting biomicroscopic visibility. (ulster.ac.uk)
  • The area covered with blood- or lymphatic vessels, respectively, was analyzed by immunohistochemistry of corneal flatmounts. (gale.com)
  • These studies agree that corneal angiogenic privilege includes several active cascades and therefore is not a passive process [ 4 - 7 ]. (hindawi.com)
  • Alkali burns are considered an ophthalmologic emergency that can induce corneal neovascularization (CNV) associated with corneal edema, increased secretion of angiogenic factors, inflammatory response, and hypoxia [ 1 ]. (hindawi.com)
  • To determine the effectiveness of multigene-based anti-angiogenic gene therapies for experimental murine corneal neovascularization (corneal NV). (molvis.org)
  • The combination of multiple anti-angiogenic genes might be necessary for effective therapy of corneal NV, although each of these pathways makes a potential target for the treatment of this disease. (molvis.org)
  • It is triggered when the balance between angiogenic and antiangiogenic factors are disrupted that otherwise maintain corneal transparency. (wikipedia.org)
  • During corneal NV, an up-regulation of angiogenic factors must be present, most likely in association with a down- regulation of anti-angiogenic molecules1. (ispub.com)
  • In addition, an occasional human tumor cell line or primary explant is able to drive nude mice in which it is growing into an antiangiogenic state in which the animals become unable to mount a corneal angiogenic response that is induced in tumor-free controls ( 5 , 6 ). (pnas.org)
  • Please note that the autofluorescence for corneal epithelium should not be misinterpreted as positive staining. (nih.gov)
  • Specific factors from the corneal epithelium underlying the stimulation of stromal fibrosis and myofibroblast formation in corneal wound healing have not been fully elucidated. (harvard.edu)
  • Histological analysis revealed a stratified corneal epithelium with at least three layers in all PF-MC animals at day 7. (biomedcentral.com)
  • Matrix metalloproteinase 13 was predominantly expressed by epithelial cells in normal rat corneas, but it was expressed by cells in corneal stromas after alkali burns. (sigmaaldrich.com)
  • Exosomes secreted by mouse corneal epithelial cells were found to fuse to keratocytes in vitro and to induce myofibroblast transformation. (harvard.edu)
  • The Cabo-NPs possessed good biocompatibility both in corneal epithelial cells and mouse corneas. (rsc.org)
  • We also offer an in vitro corneal wound healing model that utilizes primary murine or human corneal epithelial cells. (eyecro.com)
  • McDermott AM, Kern TS, Murphy CJ (1998) The effect of elevated extracellular glucose on migration, adhesion and proliferation of SV40 transformed human corneal epithelial cells. (springer.com)
  • Gomes JAP, Amankwah R, Powell-Richards A, Dua HS (2004) Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro. (springer.com)
  • Nakamura M, Mishima H, Nishida T, Otori T (1994) Binding of hyaluronan to plasma fibronectin increases the attachment of corneal epithelial cells to a fibronectin matrix. (springer.com)
  • Antibody-mediated neutrophil depletion or S100A8 depletion in mice was performed to evaluate the role of neutrophils and S100A proteins in suture-induced corneal neovascularization (S-CorNV). (nih.gov)
  • In the present study we evaluate the role of the two receptors, TNF-receptor (TNF-R)p55 and TNF-Rp75, in the mouse model of suture-induced corneal neovascularization and lymphangiogenesis. (gale.com)
  • Topical ranibizumab as a treatment of corneal neovascularization. (biomedsearch.com)
  • PURPOSE: To examine the effect of topical ranibizumab on clinically stable corneal neovascularization (NV). (biomedsearch.com)
  • Ten eyes of 9 patients with corneal NV received topical ranibizumab (1%) 4 times a day for 3 weeks with a follow-up period of 16 weeks. (biomedsearch.com)
  • CONCLUSIONS: Topical application of ranibizumab is effective in reducing the severity of corneal NV in the context of established corneal NV, mostly through decrease in VC rather than IA. (biomedsearch.com)
  • This is a single site, randomized, double masked, crossover, phase I/II study of topical IL-1Ra (5.0%) in subjects with corneal neovascularization. (clinicaltrials.gov)
  • These data support the study of novel topical antiangiogenic therapies at the cornea to precondition such a cornea for future corneal grafting. (nih.gov)
  • BACKGROUND AND OBJECTIVE:To demonstrate the effect of topical heparin combined with topical steroid on corneal neovascularization (CN) in children. (uzh.ch)
  • To evaluate the effect of topical sodium hyaluronate (SH) 0.18% treatment on corneal epithelial healing after epithelial debridement in pars plana vitrectomy in diabetic patients. (springer.com)
  • Tumor necrosis factor (TNF)[alpha] is an inflammatory cytokine likely to be involved in the process of corneal inflammation and neovascularization. (gale.com)
  • The inflammatory response in the cornea is mainly initiated and maintained by sequential migration and activation of proinflammatory cells from both innate and adaptive immune response against invading corneal P. aeruginosa infection ( 4 ). (jimmunol.org)
  • A decrease in corneal transparency causes visual acuity deterioration. (wikipedia.org)
  • However, corneal neovascularization (CNV) can occur under conditions of infection, inflammation, immune response, chemical injury, trauma and impaired corneal innervation [ 1-3 ], leading to corneal edema, lipid deposition, scar formation, persistent inflammation and a loss of visual acuity [ 4 ]. (bioscirep.org)
  • This disrupts corneal transparency and visual acuity. (eyecro.com)
  • Corneal neovascularization which can lead to compromised visual acuity occurs in a wide variety of corneal pathologies. (biomedcentral.com)
  • Corneal neovascularization can lead to a decrease in visual acuity because of oedema, persistent inflammation, intrastromal protein and lipid deposition, and scarring. (biomedcentral.com)
  • Corneal tissue is avascular in nature and the presence of vascularization, which can be deep or superficial, is always pathologically related. (wikipedia.org)
  • An anti-VEGF-A antibody that binds to murine VEGF was evaluated for effects on corneal neovascularization and fungal recovery. (molvis.org)
  • S100A proteins in the pathogenesis of experimental corneal neovascularization. (nih.gov)
  • The authors describe a patient with lipid keratopathy secondary to corneal neovascularization treated with photodynamic therapy. (healio.com)
  • Six months following treatment the neovascularization has not returned and the lipid keratopathy has not increased in size. (healio.com)
  • Photodynamic therapy with Verteporfin was a useful treatment modality in this case of corneal neovascularization with associated lipid keratopathy. (healio.com)
  • Four months later, stromal neovascularization was noted and after 5 months a lipid infiltrate was beginning to develop. (healio.com)
  • She represented in August 2005 with a concern of decreased vision and increasing size of the corneal lipid keratopathy. (healio.com)
  • The 5 mm spot size covered all of the corneal neovascularization from the limbus but did not cover the peripheral margin of lipid keratopathy in the cornea center. (healio.com)
  • Biomicroscopy showed a superior paracentral mid-stromal opacification in OR with deep stromal lipid deposition secondary neovascularization superiorly. (escrs.org)
  • This study aims at investigating the effects and molecular mechanism of riboflavin-ultraviolet-A-induced cross-linking (corneal collagen cross-linking, CXL) on corneal neovascularization (CNV) in a rabbit alkali burn model. (hindawi.com)
  • Our results indicate that riboflavin-ultraviolet-A-induced cross-linking (corneal collagen cross-linking, CXL) significantly inhibits alkali burn-induced CNV in rabbits, possibly through downregulating VEGF, MMP-2, MMP-9, and TIMP-1 expression. (hindawi.com)
  • Moreover, in a corneal alkali burn model, epithelial defects are attenuated by CXL treatment, which suggests that CXL ameliorates the effects of acute corneal alkali burns [ 6 ]. (hindawi.com)
  • Diospyros kaki extract inhibits alkali burn-induced corneal neovascularization. (greenmedinfo.com)
  • The same study found that the tissue from twenty percent of corneas examined during corneal transplantations had some degree of neovascularization, negatively impacting the prognosis for individuals undergoing keratoplasty procedures. (wikipedia.org)
  • Corneal neovascularization (corneal NV) is a central feature in the pathogenesis of many blinding corneal disorders and is also a major sight-threatening complication in corneal infections and chemical injury or after keratoplasty. (molvis.org)
  • Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis. (nih.gov)
  • Graft failure and rejection risk increase with an increasing number of corneal quadrants affected by neovascularization before keratoplasty. (nih.gov)
  • Advanced cornea NV can become permanently vision-threatening and often contributes rejection corneal grafts after keratoplasty. (eyecro.com)
  • High-dose subconjunctival cyclosporine a implants do not affect corneal neovascularization after high-risk keratoplasty. (semanticscholar.org)
  • PURPOSE To test whether subconjunctival cyclosporine A (CsA) implants affect the incidence and the degree of corneal neovascularization occurring after penetrating keratoplasty. (semanticscholar.org)
  • Since the imbalance between proangiogenic agents and antiangiogenic agents primarily mediate the process of corneal neovascularization, recent therapies are intended to disrupt the different steps in the synthesis and actions of proangiogenic factors. (biomedcentral.com)
  • However, when inducers and inhibitors are shed from the tumor bed into the circulation, levels of the more labile inducers fall off rapidly whereas levels of the more stable inhibitors rise, creating a systemic antiangiogenic environment that prevents small nests of metastatic cells from inducing neovascularization. (pnas.org)
  • These findings demonstrate that epithelial-derived exosomes may be involved in corneal wound healing and neovascularization, and thus, may serve as targets for potential therapeutic interventions. (harvard.edu)
  • The therapeutic mechanism of the Cabo-NPs is closely related to the significant decrease in proangiogenic and proinflammatory factors, suppressing neovascularization and inflammation. (rsc.org)
  • Additionally, the report provides an overview of key players involved in therapeutic development for Corneal Neovascularization and features dormant and discontinued projects. (globalmarketsdirect.com)
  • Effects of TNF[alpha] receptor TNF-Rp55- or TNF-Rp75- deficiency on corneal neovascularization and lymphangiogenesis in the mouse. (gale.com)
  • Corneal neovascularization and lymphangiogenesis were induced by three 11-0 intrastromal corneal sutures in wild-type (WT) C57BL/6J mice and TNF-Rp55-deficient (TNF-Rp55d) and TNF-Rp75-deficient (TNF-Rp75d) mice. (gale.com)
  • In the suture-induced mouse model, TNF[alpha] and its ligands TNF-Rp55 and TNF-Rp75 do not play a significant role in the pathogenesis of neovascularisation and lymphangiogenesis. (gale.com)
  • This study examines whether S100A proteins are involved in the pathogenesis of inflammation-associated corneal neovascularization (CorNV). (nih.gov)
  • Therefore, understanding the pathogenesis of P. aeruginosa corneal infection, particularly the different factors and cells that either contribute to or inhibit the corneal pathology, would reveal significant information to design novel therapeutics. (jimmunol.org)
  • After 2 month examination reveled ulcer healed with superficial corneal opacity that keep persistent all over the fellow up period of 36 month. (ispub.com)
  • neovascularization, however, can occur in pathologic conditions. (molvis.org)
  • The company is now conducting an international phase III trial with GS-101 for the prevention of pathologic corneal neovascularization and thereby corneal graft rejection. (eyedocnews.com)
  • There is ongoing research exploring techniques that might be able to induce healthy neovascularization of ischemic cardiac tissues. (wikipedia.org)
  • The inhibitory effects of the drugs on corneal neovascularization were tested and compared with each other and with controls with a computer program that evaluates percent areas of cornea covered by neovascularization. (agu.edu.tr)
  • Thymoquinone was shown to have an inhibitory effect, comparable with that of triamcinolone, on corneal neo- vascularization in this rat model. (agu.edu.tr)
  • Age-related macular degeneration (AMD) is a vision-threatening disease characterized by choroidal fibrovascular membrane (FVM) formation, choroidal neovascularization (CNV) and choroidal fibrosis. (ebscohost.com)
  • Treatments for corneal neovascularization are predominately off-lab with a multitude of complications as a result. (wikipedia.org)
  • The aim of this article is to review the most relevant treatments for corneal neovascularization available so far. (biomedcentral.com)
  • Scarified corneas of BALB/c mice were topically inoculated with Candida albicans and monitored daily for corneal neovascularization. (molvis.org)
  • Suture-induced neovascularization and infiltration in murine corneas. (nih.gov)
  • In advanced stages, corneal neovascularization can threaten eyesight, which is why routine (annual) eye exams are recommended for contact lens patients. (wikipedia.org)
  • All patients suffered from some form of corneal neovascularization (NV). (hindawi.com)
  • The charts of 10 consecutive patients with corneal neovascularisation who received single S.C. inj. (bvsalud.org)
  • The group that received the GS-101 dose of 86 µg/day showed regression in 86% of patients compared with progression of neovascularization which occurred in 100% of the placebo group. (eyedocnews.com)
  • Inhibition of corneal neovascularisation was observed after one week in all patients and continued for the whole period of observation. (escrs.org)
  • Corneal Substructure Dosimetry Predicts Corneal Toxicity in Patients with Uveal Melanoma Treated with Proton Beam Therapy. (bioportfolio.com)
  • Diabetic patients on SH 0.18% four times daily for epithelial defect had similar corneal wounds healing rate as non-diabetics. (springer.com)
  • This treatment significantly improved corneal wound healing and accelerated complete corneal wound resurfacing in diabetic patients. (springer.com)
  • Corneal transplant is a highly successful surgery in keratoconus patients in which all other treatment options have been exhausted. (healthtap.com)
  • The desired results from medical therapy may not always occur, ergo an invasive procedure may be needed to prevent further decrease in corneal avascularity. (wikipedia.org)
  • Corneal transparency is determined by many factors including avascularity. (hindawi.com)
  • Corneal avascularity is an indispensable requirement for the cornea to remain transparent and for immune privilege. (bioscirep.org)
  • A normal transparent cornea is essential to provide an appropriate anterior refractive surface, and maintaining corneal avascularity is a vital characteristic of corneal physiology. (biomedcentral.com)
  • Preoperative corneal neovascularization (CNV) is thought to be associated with an increased rate of corneal graft failure and potentially also graft rejection. (nih.gov)
  • There was evidence of incremental increase of risk for graft failure and rejection as more corneal quadrants were affected by neovascularization. (nih.gov)
  • The 2 factors predictive of increased risk of neovascularization and graft failure were increased recipient age (P = 0.003) and male gender (P = 0.046). (nih.gov)
  • Neovascularization of the cornea can disrupt visual function causing graft failure and blindness. (elsevier.com)
  • Conclusions The innate immune response to allogeneic corneal tissue is more vigorous in the presence of allergic conjunctivitis than in naive eyes and is associated with accelerated lymphatic ingrowth to host cornea. (bmj.com)
  • Gene therapy was performed by subconjunctival injection of viral preparations and its effect was evaluated by scoring corneal NV. (molvis.org)
  • In the murine corneal NV model, subconjunctival injection of the retroviral particles of mEndo and msFlk-1 showed the most significant inhibition of corneal NV. (molvis.org)
  • Overproduction of VEGF-A was observed in tumor cell proliferation, similarly to corneal neovascularization formation. (hindawi.com)
  • Immunostaining localized VEGF-A in corneal sections. (molvis.org)
  • CXL treatment decreased CNV and corneal edema in all groups compared to Group A. On day 7, MMP-9 expression was significantly increased in all CXL treatment groups, and TIMP-1 was upregulated in Groups D and F compared to Group A. In addition, VEGF, MMP-2, MMP-9, and TIMP-1 expression were increased in Group A on day 14 after injury. (hindawi.com)
  • Interestingly, requirement of VEGF in corneal NV was shown by the inhibition of NV after stromal implantation of an anti- VEGF blocking antibody in a rat model [2]. (ispub.com)
  • Anti-VEGF therapy effective in choroidal neovascularization with choroidal osteoma. (ebscohost.com)
  • Anti-VEGF Therapy to Treat Corneal Neovascularization. (ebscohost.com)
  • Photodynamic Therapy With Verteporfin for Classic Choroidal Neovascularization Secondary to Focal Laser Photocoagulation for Radiation Retinopathy. (ebscohost.com)
  • We report an unusual case of choroidal neovascularization secondary to intraocular foreign body (IOFB) penetrating trauma. (ebscohost.com)
  • A large subset of measures has been advocated to prevent and/or treat corneal neovascularization with varying degrees of success. (biomedcentral.com)
  • Corticoids chronic use can cause ocular side effects as glaucoma and cataracts and affect corneal epithelialization [ 4 - 6 ]. (biomedcentral.com)
  • A 14-year-old girl presenting with visual loss in both eyes was diagnosed to have healed toxoplasma retinochoroiditis in the right eye with active choroidal neovascularization (CNV) secondary to toxoplasmosis in the left. (ebscohost.com)
  • A 50-year-old patient developed extrafoveal predominantly classic choroidal neovascularization in the right eye 2 months after undergoing focal laser photocoagulation for macular edema with hard exudates secondary to radiation retinopathy, with vision dropping from 20/20 to 20/100. (ebscohost.com)
  • Can GS-101 Prevent Corneal Transplant Rejection? (eyedocnews.com)
  • Tips about corneal transplant as treatment for keratoconus? (healthtap.com)
  • We evaluated the number of corneal segments affected by NV, CDVA, and the incidence of complications and subjective complaints related to the treatment. (hindawi.com)
  • Azithromycin treatment increases survival of high-risk corneal allotransplants. (biomedsearch.com)
  • Riboflavin-ultraviolet-A corneal cross-linking (CXL) is an established treatment to enhance biomechanical stability, increase corneal resistance to enzymatic digestion, and inhibit corneal edema [ 3 - 5 ]. (hindawi.com)
  • The treatment of 150 J/cm 2 is three times higher than used in the treatment of choroidal neovascularization. (healio.com)
  • After treatment, 8 eyes had complete CN resolution, and 1 eye with corneal anesthesia following brain tumor resection had partial regression in vessel distribution and size. (semanticscholar.org)
  • What are any treatment options for corneal neovascularization with corneal scarring? (healthtap.com)
  • Best treatment for corneal edema/fuch's dystrophy? (healthtap.com)
  • We demonstrate in this study that local recombinant Gal-1 (rGal-1) treatment by subconjunctival injections significantly diminishes P. aeruginosa -mediated corneal inflammation through multiple mechanisms. (jimmunol.org)
  • Specifically, in our study, rGal-1 treatment significantly diminished corneal infiltration of total CD45 + T cells, neutrophils, and CD4 + T cells. (jimmunol.org)
  • Particular attention is given to the successes of translational medicine in the treatment of corneal tissue fibrosis. (deepdyve.com)
  • The use of femtosecond lasers has created an evolution in modern corneal and refractive surgery. (harvard.edu)
  • Inoue M, Katakami C (1993) The effect of hyaluronic acid on corneal epithelial cell proliferation. (springer.com)
  • The main steps of regeneration of corneal tissues and their disorders that lead to outstripping proliferation of myofibroblasts and secretion of extracellular matrix in the wound area and eventually cause the formation of connective tissue scar and corneal opacity are considered. (deepdyve.com)